<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article article-type="research-article" dtd-version="2.3" xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Cell Dev. Biol.</journal-id>
<journal-title>Frontiers in Cell and Developmental Biology</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Cell Dev. Biol.</abbrev-journal-title>
<issn pub-type="epub">2296-634X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="publisher-id">799042</article-id>
<article-id pub-id-type="doi">10.3389/fcell.2022.799042</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Cell and Developmental Biology</subject>
<subj-group>
<subject>Original Research</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Protective Effect of Minocycline Hydrochloride on the Mouse Embryonic Development Against Suboptimal Environment</article-title>
<alt-title alt-title-type="left-running-head">Hou et&#x20;al.</alt-title>
<alt-title alt-title-type="right-running-head">Minocycline Hydrochloride Protects Mouse Embryos</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname>Hou</surname>
<given-names>Xiaojing</given-names>
</name>
<xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1530053/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Cai</surname>
<given-names>Changming</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>He</surname>
<given-names>Yuanlin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1386888/overview"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname>An</surname>
<given-names>Shiyu</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Zhao</surname>
<given-names>Shuqin</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author">
<name>
<surname>Sun</surname>
<given-names>Hao</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name>
<surname>Yang</surname>
<given-names>Yang</given-names>
</name>
<xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref>
<xref ref-type="corresp" rid="c001">&#x2a;</xref>
<uri xlink:href="https://loop.frontiersin.org/people/1227841/overview"/>
</contrib>
</contrib-group>
<aff id="aff1">
<sup>1</sup>
<institution>State Key Laboratory of Reproductive Medicine</institution>, <institution>Women&#x2019;s Hospital of Nanjing Medical University</institution>, <institution>Nanjing Maternity and Child Health Care Hospital</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<aff id="aff2">
<sup>2</sup>
<institution>State Key Laboratory of Reproductive Medicine</institution>, <institution>Nanjing Medical University</institution>, <addr-line>Nanjing</addr-line>, <country>China</country>
</aff>
<author-notes>
<fn fn-type="edited-by">
<p>
<bold>Edited by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1035625/overview">Zhao-Jia Ge</ext-link>, Qingdao Agricultural University, China</p>
</fn>
<fn fn-type="edited-by">
<p>
<bold>Reviewed by:</bold> <ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1539668/overview">Manabu Ozawa</ext-link>, The University of Tokyo, Japan</p>
<p>
<ext-link ext-link-type="uri" xlink:href="https://loop.frontiersin.org/people/1565199/overview">Michele Boiani</ext-link>, Max Planck Institute for molecular biomedicine, Germany</p>
</fn>
<corresp id="c001">&#x2a;Correspondence: Yang Yang, <email>yangyang11@njmu.edu.cn</email>
</corresp>
<fn fn-type="other">
<p>This article was submitted to Molecular and Cellular Reproduction, a section of the journal Frontiers in Cell and Developmental Biology</p>
</fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>02</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>10</volume>
<elocation-id>799042</elocation-id>
<history>
<date date-type="received">
<day>21</day>
<month>10</month>
<year>2021</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>01</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#xa9; 2022 Hou, Cai, He, An, Zhao, Sun and Yang.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Hou, Cai, He, An, Zhao, Sun and Yang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these&#x20;terms.</p>
</license>
</permissions>
<abstract>
<p>Numerous studies have reported how inner cell mass (ICM) and trophectoderm (TE) was determined during the process of early mouse embryonic development from zygotes into organized blastocysts, however, multiple mysteries still remain. It is noteworthy that pluripotent stem cells (PSCs), which are derived from embryos at different developmental stages, have identical developmental potential and molecular characteristics to their counterpart embryos. Advances of PSCs research may provide us a distinctive perspective of deciphering embryonic development mechanism. Minocycline hydrochloride (MiH), a critical component for maintaining medium of novel type of extended pluripotent stem cells, which possesses developmental potential similar to both ICM and TE, can be substituted with genetic disruption of <italic>Parp1</italic> in our previous study. Though <italic>Parp1</italic>-deficient mouse ESCs are more susceptible to differentiate into trophoblast derivatives, what role of MiH plays in mouse preimplantation embryonic development is still a subject of concern. Here, by incubating mouse zygotes in a medium containing MiH till 100&#xa0;h after fertilization, we found that MiH could slow down embryonic developmental kinetics during cleavage stage without impairing blastocyst formation potential. Olaparib and Talazoparib, two FDA approved PARP1 inhibitors, exhibited similar effects on mouse embryos, indicating the aforementioned effects of MiH were through inhibiting of PARP1. Besides, we showed an embryonic protective role of MiH against suboptimal environment including long term exposure to external environment and H2O2 treatment, which could mimic inevitable manipulation during embryo culture procedures in clinical IVF laboratory. To our knowledge, it is not only for the first time to study MiH in the field of embryo development, but also for the first time to propose MiH as a protective supplement for embryo culture, giving the way to more studies on exploring the multiple molecular mechanisms on embryonic development that might be useful in assisted reproductive technology.</p>
</abstract>
<kwd-group>
<kwd>minocycline hydrochloride</kwd>
<kwd>PARP1</kwd>
<kwd>mouse embryo</kwd>
<kwd>suboptimal environment</kwd>
<kwd>ROS</kwd>
</kwd-group>
<contract-num rid="cn001">32070804 31801205&#x20;32100681</contract-num>
<contract-num rid="cn002">BK20180677</contract-num>
<contract-num rid="cn003">WSW-035</contract-num>
<contract-num rid="cn004">2019M661890 2019M651894</contract-num>
<contract-sponsor id="cn001">National Natural Science Foundation of China<named-content content-type="fundref-id">10.13039/501100001809</named-content>
</contract-sponsor>
<contract-sponsor id="cn002">Natural Science Foundation of Jiangsu Province<named-content content-type="fundref-id">10.13039/501100004608</named-content>
</contract-sponsor>
<contract-sponsor id="cn003">Six Talent Peaks Project in Jiangsu Province<named-content content-type="fundref-id">10.13039/501100010014</named-content>
</contract-sponsor>
<contract-sponsor id="cn004">China Postdoctoral Science Foundation<named-content content-type="fundref-id">10.13039/501100002858</named-content>
</contract-sponsor>
</article-meta>
</front>
<body>
<sec id="s1">
<title>Introduction</title>
<p>During early murine embryo development, the zygote undergoes a serials of cell divisions and generates a blastocyst which consists of two distinct cell types: the inner cell mass (ICM) and the trophectoderm (TE) that surrounds the ICM (<xref ref-type="bibr" rid="B35">Johnson and Ziomek 1981</xref>; <xref ref-type="bibr" rid="B26">Fleming 1987</xref>; <xref ref-type="bibr" rid="B46">Morris et&#x20;al., 2010</xref>). The TE gives rise to trophoblast lineages of placenta, and the ICM forms pluripotent epiblast, which following develops to the embryo proper and the primitive endoderm (<xref ref-type="bibr" rid="B15">Chazaud et&#x20;al., 2006</xref>). Though numerous studies have reported how these lineages are determined, multiple mysteries still remain (<xref ref-type="bibr" rid="B14">Chazaud and Yamanaka 2016</xref>).</p>
<p>Studies focused on mechanical regulation of stem cells pluripotency have offered many clues for embryonic development research (<xref ref-type="bibr" rid="B49">Nichols and Smith 2012</xref>; <xref ref-type="bibr" rid="B11">Boroviak et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B7">Baker and Pera 2018</xref>). In our previous study, extended pluripotent stem cells (EPS) were derived from blastocyst and exhibited widespread bi-potency for both embryonic and extraembryonic lineages <italic>in vivo</italic>. This novel type of pluripotent stem cells (PSCs) was maintained with a chemical cocktail, consisting of human leukemia inhibitory factor (hLIF), CHIR 99021, (S)-(&#x2b;)-dimethindene maleate (DiM) and minocycline hydrochloride (MiH), which was short for LCDM (<xref ref-type="bibr" rid="B78">Yang et&#x20;al., 2017</xref>). Notably, <italic>Parp1</italic>-deficient mouse EPS cultured in condition without MiH could develop into both TE and ICM of the embryos as well (<xref ref-type="bibr" rid="B78">Yang et&#x20;al., 2017</xref>), indicating MiH performed through inhibiting Poly (ADP-ribose) polymerase-1 (PARP1), which was consistent with the work of <xref ref-type="bibr" rid="B4">Alano et&#x20;al., 2006</xref>. What role MiH plays in the embryonic development procedure and whether it works through PARP1 inhibition are subjects of concern.</p>
<p>PARP1 is the most abundant isoform of PARP family. To date, three functionally defined domains of PARP1 has been found: 1) N-terminal DNA binding domain; 2) C-terminal catalytic domain and 3) central automodification domain (<xref ref-type="bibr" rid="B61">Rolli et&#x20;al., 1997</xref>). It is an important nuclear factor in modulating cell mitosis, DNA replication, transcription, metabolism and epigenetic events through PARylation of downstream proteins (<xref ref-type="bibr" rid="B55">Pleschke et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B65">Simbulan-Rosenthal et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B32">Hassa and Hottiger 2002</xref>; <xref ref-type="bibr" rid="B66">Simbulan-Rosenthal et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B36">Kanai et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B51">Nusinow et&#x20;al., 2007</xref>; <xref ref-type="bibr" rid="B13">Caiafa et&#x20;al., 2009</xref>). Moreover, PARP1 acts as a DNA damage sensor and binds to both single and double stranded DNA breaks (<xref ref-type="bibr" rid="B73">Virag and Szabo 2002</xref>; <xref ref-type="bibr" rid="B29">Gibson and Kraus 2012</xref>), promoting both base excision repair and homologous recombination (<xref ref-type="bibr" rid="B12">Burkle 2001</xref>; <xref ref-type="bibr" rid="B23">Curtin 2013</xref>). Studies in somatic cells indicate that when PARP1 activated, it attaches PAR units which were derived from NAD<sup>&#x2b;</sup> to various nuclear proteins including itself, histones and other nuclear proteins such as transcription factors (<xref ref-type="bibr" rid="B22">Cohen-Armon 2007</xref>; <xref ref-type="bibr" rid="B33">Hinz et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B39">Kraus and Hottiger 2013</xref>). Several works have proved that genetic and pharmaceutical disruption of PARP1 in oxidative stress played a protective role against cell death by maintaining integrity of mitochondrial membrane and activating phosphatidylinositol-3 kinase (PI3K)-AKT signal pathway (<xref ref-type="bibr" rid="B72">Veres et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B71">Tapodi et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B8">Bartha et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B44">Mester et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B69">Szanto et&#x20;al., 2009</xref>).</p>
<p>Oxidative stress, a cellular condition caused by the accumulation of reactive oxygen species (ROS), have been repeatedly shown to be prevalent in defective embryo development and result in suboptimal pregnancy rates (<xref ref-type="bibr" rid="B31">Guerin et&#x20;al., 2001</xref>; <xref ref-type="bibr" rid="B38">Kovacic and Vlaisavljevic 2008</xref>; <xref ref-type="bibr" rid="B21">Ciray et&#x20;al., 2009</xref>; <xref ref-type="bibr" rid="B74">Waldenstrom et&#x20;al., 2009</xref>). Although numerous studies have reported the effects of individual antioxidants on embryo development (<xref ref-type="bibr" rid="B27">Fujitani et&#x20;al., 1997</xref>; <xref ref-type="bibr" rid="B5">Ali et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B37">Kitagawa et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B18">Choe et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B64">Silva et&#x20;al., 2015</xref>), it seems that none of the available ones can fully mimic the physiological conditions of the female tract (<xref ref-type="bibr" rid="B6">Aviles et&#x20;al., 2010</xref>).</p>
<p>Taking all this information into consideration, we sought to determine whether MiH can improve embryo quality in suboptimal culture environment.</p>
</sec>
<sec sec-type="materials|methods" id="s2">
<title>Materials and Methods</title>
<sec id="s2-1">
<title>Animals and Ethics</title>
<p>ICR mice (5&#x2013;6&#xa0;weeks female and 10&#xa0;weeks old male) were purchased from Animal Care Facility of Nanjing Medical University and were housed in ventilated cages at constant temperature (22&#xb0;C) and controlled humidity and light dark cycle. All animal experiments were approved by the Animal Care and Use Committee of Nanjing Medical University and were performed in accordance with institutional guidelines.</p>
</sec>
<sec id="s2-2">
<title>Antibodies</title>
<p>Rabbit polyclonal anti-OCT4 antibody (Cat&#x23;: ab181557) was purchased from Abcam (Cambridge, MA, United&#x20;States); mouse monoclonal anti-CDX2 antibody (Cat&#x23;:AM392-5M) was purchased from BioGenex (Fremont, United&#x20;States); mouse monoclonal PAR/pADPr antibody (Cat&#x23;:4335-MC-100) was purchased from R&#x26;D Systems (Minnesota, United&#x20;States). Donkey anti-Mouse Alexa Fluor 488, 555 and Donkey anti-Rabbit Alexa Fluor 555 antibodies (Cat&#x23;: A21202, A31570, A31572) were purchased from Thermo Fisher Scientific (Rockford,&#x20;IL).</p>
</sec>
<sec id="s2-3">
<title>
<italic>In vitro</italic> Fertilization and Embryo Culture</title>
<p>To promote ovulation, female mice were intraperitoneally injected with 7 IU Pregnant Mare Serum Gonadotropin (PMSG) followed by 7 IU of Human Chorionic Gonadotropin (hCG) after PMSG priming. Cumulus-oocyte complexes (COC) were isolated from oviduct ampullae 14&#x2013;15&#xa0;h post-hCG injection and were cultured in drops of HTF fertilization medium under mineral oil. Sperm was collected from the tail of epididymis of adult male mice and incubated in HTF fertilization medium at 37&#xb0;C in a 5% CO2 incubator for 1&#xa0;h before fertilization. Then capacitated spermatozoon was added to HTF drops containing COC and co-cultured together for 6&#xa0;h in the incubator to allow for fertilization. Zygotes were then washed and transferred into drops of KSOM (Aibei Biotechnology, Nanjing, M1450) medium supplemented with chemical inhibitors or not. Chemical inhibitors were used at the following concentrations: 2&#xa0;&#x3bc;M Minocycline hydrochloride (MiH, Selleck, S4226); 20, 50 or 100&#xa0;nM Olaparib (Ola, APExBio, A4154); 0.2, 0.5 or 1&#xa0;nM Talazoparib (Tala, APExBio, A4153). Embryos were observed and imaged with an inverted phase-contrast microscopy (Nikon Ts2R, Japan).</p>
</sec>
<sec id="s2-4">
<title>Immunostaining</title>
<p>Embryos were fixed in 4% paraformaldehyde for 15&#xa0;min and then were permeabilized with PBS containing 0.2% Triton X-100 for 10&#xa0;min at room temperature (RT). After being blocked for 1&#xa0;h in blocking buffer, which comprised of PBS together with 0.1% BSA, 0.01% Tween-20 and 2.5% donkey serum, embryos were incubated with primary antibodies diluted in blocking buffer overnight at 4&#xb0;C. Embryos were then washed for three times with PBS and labeled with secondary antibodies in the dark for 1&#xa0;h at RT. Samples were then washed for three times with PBS and stained with 1&#xa0;&#x3bc;g/ml DAPI for 5&#xa0;min, and washed for three times before mounting on glass slides in small drops of antifade medium. Samples were then imaged using an inverted phase-contrast microscopy (Nikon Ts2R, Japan).</p>
</sec>
<sec id="s2-5">
<title>
<italic>In Vitro</italic> Exposure of Mouse Zygotes and Developmental Potential Tests Beyond Preimplantation</title>
<p>Zygotes were collected in drops of HTF medium after fertilization and place them on the warmed microscope stage for 1&#xa0;h at 37&#xb0;C. Zygotes were then transferred to the KSOM medium with or without MiH to culture.</p>
<p>After 100&#xa0;h, the blastocysts of the above three groups were randomly selected and surgically transferred into the uteri of pseudopregnant female mice. 9&#x20;days after transferring, mice were euthanized to see whether they were pregnant.</p>
<p>An IVC assay was also carried out to observe the developmental potential <italic>in&#x20;vitro</italic> by culturing the rest of blastocysts in the afore mentioned experiments according to a protocol we used before (<xref ref-type="bibr" rid="B82">Zhao et&#x20;al., 2021</xref>). All the blastocysts were embedded in Matrigel drops and culture for further 120&#xa0;h to see whether they could form egg cylinder structures.</p>
</sec>
<sec id="s2-6">
<title>Mouse Zygotes Model for Oxidative Damage</title>
<p>Zygotes were incubated in HTF fertilization medium containing 0.1&#xa0;mM H2O2 for 1&#xa0;h at 37&#xb0;C, then washed with fresh HTF fertilization medium three times to remove H2O2 and transferred into KSOM medium for further culture. NAC group of ROS measurement experiment were performed as control by addition of N-Acetyl-l-cysteine (Sigma-Aldrich, A9165) to a working concentration of 5&#xa0;mM.</p>
</sec>
<sec id="s2-7">
<title>TUNEL Assay</title>
<p>TUNEL assay was carried out to analyze apoptosis of embryos using One Step TUNEL Apoptosis Assay Kit (Beyotime, C1086) in accordance with the instruction manual. Embryos were fixed in 4% paraformaldehyde for 30&#xa0;min and permeabilized in PBS containing 0.5% Triton X-100 for 5&#xa0;min. Then embryos were incubated in the TUNEL reaction mixture (containing FITC-conjugated dUTP and terminal deoxynucleotidyl transferase) at 37&#xb0;C in the dark for 1&#xa0;h. The reaction was terminated by washing in washing buffer (containing 0.1% Tween-20 and 0.1% BSA in PBS) for three times. Finally, the embryos were stained with DAPI for 5&#xa0;min at RT and washed before mounting on glass slides. The TUNEL labeling was observed using a fluorescence microscope (Nikon Ts2R, Japan).</p>
</sec>
<sec id="s2-8">
<title>Detection of ROS Content in Embryos</title>
<p>2,7-dichlorodihydrofluorescein diacetate (DCFH-DA) was used to evaluate the intracellular ROS level in embryos. Embryos were incubated in KSOM medium supplemented with 10&#xa0;&#x3bc;M DCFH-DA for 30&#xa0;min at 37&#xb0;C in a 5% CO2 incubator and stained with Hoechst 33342 for 10&#xa0;min. Fluorescence was observed under a Laser Scanning Confocal Microscope (LSM 710, Zeiss, Germany) at a 488&#xa0;nm excitation wavelength and analyzed with the Image J software.</p>
</sec>
<sec id="s2-9">
<title>Statistical Analysis</title>
<p>Statistical analysis was performed using GraphPad Prism 7 software and all results were presented as means&#x20;&#xb1; standard deviation from three independent experiments. Data were analyzed with the Student&#x2019;s t-test. &#x2217;0.01&#x3c;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2217;&#x2217;<italic>p</italic>&#x20;&#x3c; 0.01; no labeling indicates no statistical significance.</p>
</sec>
</sec>
<sec sec-type="results" id="s3">
<title>Results</title>
<sec id="s3-1">
<title>MiH-Treated Embryos Developed Slower During Cleavage Stage but Formed Blastocyst Normally</title>
<p>Firstly, to decipher the effect of MiH on preimplantation mouse embryos, <italic>in&#x20;vitro</italic> fertilization (IVF) was employed to obtain zygotes, which were randomized into two groups and cultured with KSOM medium in the absence (control group) or presence of 2&#xa0;&#x3bc;M MiH (MiH group) till most of them developed into blastocysts at 100&#xa0;h after fertilization (<xref ref-type="fig" rid="F1">Figure&#x20;1A</xref>). We found that almost all embryos in MiH group progressed normally at 2-cell and 4-cell stages (<xref ref-type="sec" rid="s11">Supplementary Figure S1A</xref>) and there were no statistical differences in the rates of 2-cell or 4-cell embryos to total zygotes at 16&#xa0;h or 40&#xa0;h, respectively (<xref ref-type="sec" rid="s11">Supplementary Figures S1B,C</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption>
<p>MiH-treated embryos developed slower during cleavage stage but formed blastocyst normally. <bold>(A)</bold> Time scheme of <italic>in&#x20;vitro</italic> fertilization (IVF) and main procedure of MiH treatment assay of mouse embryos. <bold>(B&#x2013;D)</bold> Representative images and frequencies of embryos observed at 53&#xa0;h <bold>(B)</bold>, 70&#xa0;h <bold>(C)</bold> and 100&#xa0;h <bold>(D)</bold> after fertilization in control (<italic>n</italic>&#x20;&#x3d; 65) and MiH-treated (<italic>n</italic>&#x20;&#x3d; 60) groups. Bar &#x3d; 100&#xa0;&#x3bc;m. <bold>(E)</bold> Quantitative analysis of cavitied, expanded and hatching blastocysts at 100&#xa0;h. Dotted arrow, arrowheads and arrows indicated the cavitied, expanded and hatching blastocysts respectively. <bold>(F)</bold> Cell number of each expanded or hatching blastocyst at 100&#xa0;h. Data are presented as mean&#x20;&#xb1; SD in three independent experiments and student&#x2019;s t&#x20;tests are used for statistical analysis. &#x2217;0.01&#x3c;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2217;&#x2217;<italic>p</italic>&#x20;&#x3c; 0.01; no labeling indicates no statistical significance.</p>
</caption>
<graphic xlink:href="fcell-10-799042-g001.tif"/>
</fig>
<p>However, MiH-treated embryos showed slower progression of development since 53&#xa0;h, with only 50% of embryos being consisted of 7&#x2013;8 cells while that of control group was nearly 65% (<xref ref-type="fig" rid="F1">Figure&#x20;1B</xref>). Then nearly 90% of embryos in both groups would undergo compaction and continue to form morula at 70&#xa0;h (<xref ref-type="fig" rid="F1">Figure&#x20;1C</xref>). In order to count the cell number of each embryo, we stained nuclei with DAPI and found that the count of each morula in MiH group was significantly fewer than that in control group (<xref ref-type="sec" rid="s11">Supplementary Figures S1C,D</xref>), indicating a slower developmental kinetics as well. The difference became more evident at 85&#xa0;h, with only 45% of zygotes formed blastocysts, whereas the efficiency of control group was about 70% (<xref ref-type="sec" rid="s11">Supplementary Figures S1A,C</xref>). Notably, the blastocyst formation efficiencies of the two groups were comparable at 100&#xa0;h (<xref ref-type="fig" rid="F1">Figure&#x20;1D</xref>).</p>
<p>In order to further determine whether there was any other difference in the blastocysts, we classified blastocysts into three types depending on their expansion level as cavitated, expanded and hatching. The cavitated blastocyst is one whose blastocele has already formed, but it later continues to fill with fluid so that the blastocyst can expand. When it is expanded, the blastocyst is larger and the zona pellucida is thinner, so hatching can begin (<xref ref-type="fig" rid="F1">Figure&#x20;1D</xref>). We analyzed the frequencies of these three types of blastocysts in the two groups and found a higher ratio of cavitated blastocyst in the company with lower ratios of expanded and hatching blastocyst in MiH group without statical significance (<xref ref-type="fig" rid="F1">Figures 1D,E</xref>), which could be attributed to the slower developmental rate. However, the total cell number per blastocyst was comparable between the ones in control and MiH group at 100&#xa0;h (<xref ref-type="fig" rid="F1">Figure&#x20;1F</xref>). Here, cavitated blastocysts in the two groups were excluded for statistics because of the great individual variation. Combined these data, we could not exclude the possibility that the above phenomenon was caused by slower pumping of fluid into the blastocyst cavity.</p>
<p>In brief, MiH would develop slower during cleavage stage but formed blastocyst with similar efficiency at last. These were not consistent with findings of T. Osada<italic>et&#x20;al.</italic> and Imamura T <italic>et&#x20;al.</italic>, who used 3-ABA, PJ-34 and 5-AIQ. The inconsistency perhaps was related with inappropriate does and different side effects among inhibitors.</p>
</sec>
<sec id="s3-2">
<title>MiH Affected Embryo Development Through Inhibiting PARP1</title>
<p>For the maintenance of EPS self-renewal, MiH can be replaced by other PARP1 inhibitors and <italic>Parp1</italic>-deficient mouse EPS could contribute to both TE and ICM in the absence of MiH (<xref ref-type="bibr" rid="B78">Yang et&#x20;al., 2017</xref>). We further examined whether the influence of MiH on embryonic development was through inhibiting PARP1 as well. Olaparib (Ola) and Talazoparib (Tala) were two Food and Drug Administration (FDA) approved canonical PARP1 inhibitors that recommended for the treatment of various cancers (<xref ref-type="bibr" rid="B59">Robson et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B40">Litton et&#x20;al., 2018</xref>). Then we treated zygotes with 20, 50 and 100&#xa0;nM Ola and 0.2, 0.5 and 1&#xa0;nM Tala. Nearly half of the zygotes were impaired in higher concentrations groups while embryos in 20&#xa0;nM Ola and 0.2&#xa0;nM Tala-treated groups progressed normally (<xref ref-type="sec" rid="s11">Supplementary Figure S2</xref>). To further evaluate effects of PARP1 inhibitors at lower concentrations on embryonic development, we traced embryos in the four groups at multiple timepoints during blastocysts formation. We noticed that embryos treated with 20&#xa0;nM Ola or 0.2&#xa0;nM Tala showed no difference in the formation efficiencies of 2-cell nor 4-cell at 16 and 40&#xa0;h respectively (<xref ref-type="sec" rid="s11">Supplementary Figure S3</xref>), similar to those in MiH group (<xref ref-type="sec" rid="s11">Supplementary Figure S1</xref>). However, embryos treated with PARP1 inhibitors turned to develop slower at 53&#xa0;h, with only 40% of zygotes in Ola group contained 7&#x2013;8 blastomeres. The ratio of Tala group was about 35%, comparable to that of MiH group but significantly less than that of control group (<xref ref-type="fig" rid="F2">Figures 2A,B</xref>). The delay turned to be obvious at 85&#xa0;h that the blastocyst formation rates were significantly decreased in Ola- and Tala-treated groups (<xref ref-type="fig" rid="F2">Figures 2A,C</xref>), whereas the final outcome was not impaired (<xref ref-type="fig" rid="F2">Figures 2A,D</xref>). Moreover, embryos treated with Tala developed most slowly among those in four groups, which might be ascribed to the most potent effects of inhibition on PARP1 (<xref ref-type="bibr" rid="B47">Murai et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B48">Murai et&#x20;al., 2014</xref>).</p>
<fig id="F2" position="float">
<label>FIGURE 2</label>
<caption>
<p>Canonical PARP1 inhibitors showed similar effects on preimplantation embryos. <bold>(A)</bold> Brightfield images of embryos in control, MiH-, Olaparib (Ola)- and Talazoparib (Tala)-treated groups at 53, 85 and 100&#xa0;h after fertilization. Bar &#x3d; 100&#xa0;&#x3bc;m. <bold>(B&#x2013;D)</bold> Frequencies of embryos observed at 53&#xa0;h <bold>(B)</bold> and blastocyst formation efficiencies at 85&#xa0;h <bold>(C)</bold> and 100&#xa0;h <bold>(D)</bold>. <italic>n</italic> (Control) &#x3d; 46, <italic>n</italic> (MiH) &#x3d; 44, <italic>n</italic> (Ola) &#x3d; 45, <italic>n</italic> (Tala) &#x3d; 43. <bold>(E,F)</bold> Staining and fluorescence intensity of expanded blastocysts in the four groups for PAR. Bar &#x3d; 50&#xa0;&#x3bc;m. Data are presented as mean&#x20;&#xb1; SD in three independent experiments and student&#x2019;s t&#x20;tests are used for statistical analysis. &#x2217;, 0.01&#x3c;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2217;&#x2217;, <italic>p</italic>&#x20;&#x3c; 0.01; no labeling indicates no statistical significance.</p>
</caption>
<graphic xlink:href="fcell-10-799042-g002.tif"/>
</fig>
<p>To further address whether PARP1 was inhibited in embryos treated with MiH, Ola and Tala, PAR (poly ADP-ribose polymer), a product of PARP1 activity, was detected with an anti-PAR antibody to assess inhibition. It was previously reported that distribution of PAR remained diffused and cytosolic during preimplantation development (<xref ref-type="bibr" rid="B34">Imamura et&#x20;al., 2004</xref>). As shown in <xref ref-type="fig" rid="F2">Figures 2E,F</xref>, the distribution of PAR was diffuse and cytosolic in some cells of blastocysts in control group. On the contrary, embryos cultured in KSOM supplemented with MiH, Ola and Tala showed no signal. These results suggest that PARP1 was inhibited by MiH and two other well-known PARP1 inhibitors as previous reports.</p>
<p>MiH is a critical chemical compound for EPS cells maintenance (<xref ref-type="bibr" rid="B78">Yang et&#x20;al., 2017</xref>). We hypothesized that MiH played similar roles in first cell fate decision that generated populations of outside cells and inside cells, respectively. This is a critical developmental stage because the embryo must allocate its blastomeres into either TE or ICM. To determine whether supplementation of MiH, Ola or Tala would affect the specification of TE and ICM, immunostaining for CDX2 and OCT4 was applied (<xref ref-type="bibr" rid="B54">Palmieri et&#x20;al., 1994</xref>; <xref ref-type="bibr" rid="B50">Niwa et&#x20;al., 2005</xref>; <xref ref-type="bibr" rid="B67">Strumpf et&#x20;al., 2005</xref>). As shown in <xref ref-type="sec" rid="s11">Supplementary Figure S4A</xref>, OCT4 was almost expressed in each blastomere, while CDX2 was only expressed in the cells which lately develop into TE at 70&#xa0;h. All of the PARP1&#x20;inhibitors-treated embryos contained much more CDX2&#x2b;/OCT4&#x2b; cells than untreated ones but significantly fewer CDX2-/OCT4&#x2b; cells. When blastocyst forms, OCT4 and CDX2 is restricted to ICM and TE cells separately, with several CDX2&#x2b;/OCT4&#x2b; cells exist. In PARP1&#x20;inhibitors-treated blastocysts, more CDX2&#x2b; cells emerged with fewer CDX2-/OCT4&#x2b; cells remaining (<xref ref-type="sec" rid="s11">Supplementary Figure S4B</xref>), indicating that PARP1 inhibition might promote specification of TE identity, similar to the effect of MiH on EPS&#x20;cells.</p>
<p>Thus, we supposed that MiH affected embryo development through inhibiting PARP1 and boosted a trophoblast&#x20;bias.</p>
</sec>
<sec id="s3-3">
<title>MiH Protected Zygotes From Long-Term Exposure to External Environment</title>
<p>
<italic>In vitro</italic> fertilization (IVF) is an effective clinical strategy for the couple who fail to conceive. While the percentage of successes is much higher nowadays, one of the most plausible causes of the failure of IVF procedures is the poor quality of gametes leading to aberrant embryonic development. Previous Studies have shown that psychological stress can exert detrimental effects on reproduction in women. <italic>In vitro</italic> fertilization techniques, in particular, gametes collection, manipulation, and culture may generate stress environment which would cause oxidative stress. Furthermore, some studies suggested that inhibited PARP activity could protect against the loss of cell viability, preserve NAD &#x2b; levels and improve cellular bioenergetics in <italic>in&#x20;vitro</italic> experiments in U937 cells subjected to oxidative stress (<xref ref-type="bibr" rid="B3">Ahmad et&#x20;al., 2019</xref>). Thus, we wonder whether MiH could restore the outcome of the embryos under stressful environment. To verify this hypothesis, we placed zygotes on the warmed microscope stage for 1&#xa0;h, then cultured them in medium in the absence (<italic>in&#x20;vitro</italic> exposure, IVE) or presence of MiH (IVE&#x2b;MiH). The ratios of 2-cell and 4-cell embryos were strikingly resembling in all groups (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>, <xref ref-type="sec" rid="s11">Supplementary Figures S5A,B</xref>). Since 53&#xa0;h, zygotes in IVE and IVE&#x2b;MiH groups developed slowly, with no more than 50% of them reaching 8-cell stage while the ratio of control group was 80% (<xref ref-type="sec" rid="s11">Supplementary Figures S5A,C</xref>). Later, nearly 90% of zygotes in IVE&#x2b;MiH group developed into morula, which was much higher than that of IVE group and was comparable to control group (91 vs. 96% control; 83 vs. 96% control) (<xref ref-type="sec" rid="s11">Supplementary Figures S5A,D</xref>). Though long-term exposure to external environment significantly reduced blastocyst formation efficiencies of embryos in both IVE and IVE&#x2b;MiH groups at 85&#xa0;h (<xref ref-type="sec" rid="s11">Supplementary Figures S5A,E</xref>), the supplement of MiH rescued the final blastocyst formation potential of embryos in IVE&#x2b;MiH group, with equivalent ratio (93%) to that of control group, but significantly higher than that of IVE group (77%) at 100&#xa0;h (<xref ref-type="fig" rid="F3">Figures 3A,B</xref>). Additionally, the average cell number of blastocysts in IVE group was markedly less than that in control and IVE&#x2b;MiH groups (<xref ref-type="fig" rid="F3">Figure&#x20;3C</xref>). Analogously, the frequency of hatching blastocyst in IVE group decreased dramatically than that of control and IVE&#x2b;MiH groups, while the ratio of cavitated blastocyst exhibited much higher in IVE group (<xref ref-type="fig" rid="F3">Figure&#x20;3D</xref>). All these data above suggested that MiH played a protective role for preimplantation embryos in the process of suffering long-term exposure to environment.</p>
<fig id="F3" position="float">
<label>FIGURE 3</label>
<caption>
<p>PARP1 inhibitors could protect preimplantation mouse embryos from exposure to external environment. <bold>(A,B)</bold> Representative images and frequencies of 2-cell embryo observed at 16&#xa0;h and blastocyst at 100&#xa0;h after fertilization. Control, zygotes were transferred into incubators soon after washing and cultured in KSOM condition till 100&#xa0;h; IVE and IVE&#x2b;MiH, zygotes were exposed to external environment for 1&#xa0;h and then were transferred into incubator and cultured in KSOM without (IVE) or with MiH supplemented (IVE&#x2b;MiH). Bar &#x3d; 100&#xa0;&#x3bc;m. <bold>(C)</bold> Comparison of cell numbers of blastocyst at 100&#xa0;h. <bold>(D)</bold> Ratios of cavitated, expanded and hatching blastocysts at 100&#xa0;h. 46, 49, 47 embryos were totally counted in Control, IVE and IVE&#x2b;MiH groups. <bold>(E&#x2013;G)</bold> Immunofluorescent images of blastocysts and cell numbers in each blastocyst at 100&#xa0;h. CDX2 (green) and OCT4 (red) were used as markers for TE and ICM separately. Bar &#x3d; 50&#xa0;&#x3bc;m. <italic>N</italic> (Control) &#x3d; 12, <italic>n</italic> (IVE) &#x3d; 11, <italic>n</italic> (IVE&#x2b;MiH) &#x3d; 18. <bold>(H)</bold> Staining images of expanded blastocysts in the three groups for PAR. Bar &#x3d; 50&#xa0;&#x3bc;m. <bold>(I)</bold> Fluorescent images of ROS for expanded blastocysts. Bar &#x3d; 100&#xa0;&#x3bc;m. <bold>(J,K)</bold> Quantification intensity levels for PAR <bold>(J)</bold> and ROS <bold>(K)</bold> in in Control, IVE and IVE&#x2b;MiH groups. Data are presented as mean&#x20;&#xb1; SD in three independent experiments and student&#x2019;s t&#x20;tests are used for statistical analysis. &#x2217;0.01&#x3c;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2217;&#x2217;<italic>p</italic>&#x20;&#x3c; 0.01; no labeling indicates no statistical significance.</p>
</caption>
<graphic xlink:href="fcell-10-799042-g003.tif"/>
</fig>
<p>In order to further address whether these recovered blastocysts possessed normal developmental potential beyond preimplantation stage, they were randomly selected from the three groups and surgically transferred into the uteri of pseudopregnant female mice. 9&#xa0;days after transferring, only one which had been transferred with blastocysts in IVE&#x2b;MiH group was pregnant, indicating that MiH may partly rescue the embryo developmental potential from long time exposure to the external environment (<xref ref-type="sec" rid="s11">Supplementary Figure S6</xref>). However, we could not make a very solid conclusion that embryos in this group possessed better developmental potential beyond preimplantation stage, due to the limited sample size and failure of control group. Actually, a satisfyingly pregnant rate of embryo transplantation experiment will be inevitably affected by the uncertainty of embryo implantation even in the presence of what appears to be a receptive endometrium. It is well known that late blastocyst development is delayed in embryos in <italic>in&#x20;vitro</italic> culture relative to their <italic>in vivo</italic> counterparts. However, we had to culture all of the embryos for 100&#xa0;h to ensure the restoration of the suboptimal environmental exposure, perhaps resulting in the miss of appropriate transplanting time, especially for those unexposed ones. This perhaps in turn led to embryo-endometrial desynchronization of control&#x20;group.</p>
<p>We also performed an IVC assay to observe the developmental potential <italic>in&#x20;vitro</italic> by culturing the rest of blastocysts in the afore mentioned experiments according to a protocol we used before (<xref ref-type="bibr" rid="B82">Zhao et&#x20;al., 2021</xref>). However, the egg cylinder formation efficiencies of all the three groups were as low as less than 10%, hardly to say whether IVE&#x2b;MiH blastocysts obtained better further developmental potential. When the natural fertilized and <italic>in vivo</italic> developed E3.5 embryos were used, in the previous studies, the efficiencies were only 30&#x2013;40% as well (<xref ref-type="bibr" rid="B9">Bedzhov et&#x20;al., 2014</xref>; <xref ref-type="bibr" rid="B82">Zhao et&#x20;al., 2021</xref>), which could partly explain the low efficiency in our experiments. Though both the transplantation and IVC assays were statistically not conclusive, they provide some hints of what to expect if the experiments were performed many&#x20;times.</p>
<p>Clinical data collected in recent years proved that embryo culture impaired embryonic developmental potential including delaying cell cycle kinetics and reducing TE cells in blastocysts (<xref ref-type="bibr" rid="B30">Giritharan et&#x20;al., 2007</xref>). We then asked whether IVE affected the specification of TE and ICM and observed significant reduction of CDX2 positive cell numbers of blastocysts in both IVE and IVE&#x2b;MiH groups comparing with those in control and MiH groups. However, blastocysts in IVE&#x2b;MiH group contained much more CDX2 positive cells than those in IVE group, implying that MiH might protect TE cells from environmental stress (<xref ref-type="fig" rid="F3">Figure&#x20;3F</xref>). Meanwhile, blastocysts in all three groups had much less OCT4 positive cells when they were compared with ones in control group, with great variations between individuals in IVE group (<xref ref-type="fig" rid="F3">Figure&#x20;3G</xref>). Hence, we supposed the protective effect of MiH might be partly attributed to its boost of cells into a TE&#x20;fate.</p>
<p>Long term exposure to external environment may lead to unexpected pH and temperature shifts in the embryo culture medium. Alternation in pH has been shown to influence intracellular homeostasis, with particular effects, including protein synthesis, mitochondrial function, cellular metabolism, and cytoskeletal remodeling (<xref ref-type="bibr" rid="B75">Will et&#x20;al., 2011</xref>). Temperature is another important factor for embryonic development, which will influence integrity of spindles and DNA fragmentation. It has been reported that over-activation of PARP1 led to apoptotic and necrotic cell death during Myocardial ischemia-reperfusion injury (<xref ref-type="bibr" rid="B58">Raedschelders et&#x20;al., 2012</xref>). To confirm whether long term exposure to external environment would cause PARP1&#x20;over-activation, we performed immunodetection of PAR and found a significant stronger signal in embryos of IVE group, which exhibited weaker in embryos of both control and IVE&#x2b;MiH groups (<xref ref-type="fig" rid="F3">Figures&#x20;3H,J</xref>).</p>
<p>Besides, unavoidable environmental factors, such as light exposure, excess temperature and pH fluctuation of culture medium, which increase ROS production, have been recognized to negatively affect embryo developmental potential and result in suboptimal pregnancy rates (<xref ref-type="bibr" rid="B1">Agarwal et&#x20;al., 2005a</xref>). For this reason, we wondered whether long term exposure to external environment induced the production of ROS. To verify this problem, we explored the intracellular ROS level at 100&#xa0;h. Fluorescent analysis showed robust signal in the embryos of IVE group while supplementing culture medium with MiH could restore it to normal level (<xref ref-type="fig" rid="F3">Figures 3I,K</xref>). Thus, MiH might reduce the adverse effects of long-term exposure to external environment on embryos through inhibiting the generation of&#x20;ROS.</p>
</sec>
<sec id="s3-4">
<title>PARP1 Inhibitors Might Improve Embryo Viability Against Oxidative Injury</title>
<p>Having shown that MiH could partly reduce ROS level in embryos that exposed to external environment, we assessed whether PARP1 inhibitors would improve embryo viability against oxidative damage. Hydrogen peroxide (H2O2) is one of the strongest oxidants and will lead to overproduction of ROS. However, increased ROS production induces multiple cellular damages and mitochondrial alternation, which consequently disturbs embryonic development of preimplantation embryos <italic>in&#x20;vitro</italic> (<xref ref-type="bibr" rid="B41">Liu et&#x20;al., 2000</xref>; <xref ref-type="bibr" rid="B37">Kitagawa et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B81">Zhang et&#x20;al., 2010</xref>). Accordingly, zygotes were randomly divided into untreated and treated groups. In the treated group, zygotes were exposed to 100&#xa0;&#x3bc;M H2O2 for 1&#xa0;h, washed extensively, and then cultured in medium with (H2O2&#x2b;MiH) or without MiH (H2O2) while untreated zygotes were incubated in HTF for 1&#xa0;h and then cultured in KSOM medium (Control) (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). Since 40&#xa0;h, H2O2-treated zygotes in both two groups (H2O2&#x2b;MiH and H2O2) exhibited lower rates of 4-cell and 8-cell stages embryos (<xref ref-type="sec" rid="s11">Supplementary Figure S7</xref>). Only zygotes in H2O2 group showed decreased rates of morula at 70&#xa0;h (<xref ref-type="fig" rid="F4">Figures 4B,C</xref>). Furthermore, though blastocyst formation efficiencies of H2O2&#x2b;MiH, H2O2-treated zygotes were both much lower than those of non-treated ones at 85&#xa0;h (<xref ref-type="fig" rid="F4">Figure&#x20;4D</xref>), rate of H2O2&#x2b;MiH group was restored to the equivalent level of control group at 100&#xa0;h (<xref ref-type="fig" rid="F4">Figure&#x20;4E</xref>). Morphologic analysis also revealed that treatment of zygotes with H2O2 induced fragmentation and developmental retardation during this process, while embryos in H2O2&#x2b;MiH and control group exhibited less (<xref ref-type="fig" rid="F4">Figure&#x20;4B</xref>). Moreover, the average cell numbers of blastocysts at 100&#xa0;h significantly decreased in the H2O2 and H2O2&#x2b;MiH groups than that of control group (<xref ref-type="fig" rid="F4">Figure&#x20;4F</xref>). To further address the influence of H2O2 on cell fate decision, embryos were immunostained with CDX2 and OCT4 antibodies. We found that though CDX2 positive cell numbers decreased both in H2O2 and H2O2&#x2b;MiH treated ones, blastocysts in H2O2&#x2b;MiH group had much more CDX2 positive cells than those in H2O2 group. By contrast, no restoration of OCT4 positive cells were found in H2O2&#x2b;MiH treated ones (<xref ref-type="fig" rid="F4">Figures 4G&#x2013;I</xref>), implying that the protective effect of MiH was associated with protection for TE&#x20;cells.</p>
<fig id="F4" position="float">
<label>FIGURE 4</label>
<caption>
<p>MiH improved mouse preimplantation embryos viability against oxidative stress. <bold>(A)</bold> Main procedure of oxidative embryo model and MiH treatment assay. <bold>(B)</bold> Representative images of embryos in control and H2O2-treated groups with or without MiH at 70, 85, 100&#xa0;h after fertilization. Bar &#x3d; 100&#xa0;&#x3bc;m. Control referred to embryos who had not suffered from H2O2 treatment and cultured under KSOM; H2O2 and H2O2&#x2b;MiH referred to zygotes who were treated with 0.1&#xa0;mM H2O2 for 1&#xa0;h and then cultured under KSOM in the absence (H2O2) or presence of MiH (H2O2&#x2b;MiH), respectively. <bold>(C&#x2013;E)</bold> Morula or blastocyst formation efficiencies at 70&#xa0;h <bold>(C)</bold>, 85&#xa0;h <bold>(D)</bold> and 100&#xa0;h <bold>(E)</bold> after fertilization. 44, 47, 45 embryos were totally counted in control, H2O2- and H2O2&#x2b;MiH-treated groups, respectively. <bold>(F)</bold> Comparison of cell numbers of blastocyst at 100&#xa0;h <bold>(G&#x2013;I)</bold> Immunofluorescent images of blastocysts at 100&#xa0;h. CDX2 (green) and OCT4 (red) were used as markers for TE and ICM separately. Bar &#x3d; 50&#xa0;&#x3bc;m. <italic>N</italic> (Control) &#x3d; 26, <italic>n</italic> (H2O2) &#x3d; 34, <italic>n</italic> (H2O2&#x2b;MiH) &#x3d; 31. Data are presented as mean&#x20;&#xb1; SD in three independent experiments and student&#x2019;s t&#x20;tests are used for statistical analysis. &#x2217;0.01&#x3c;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2217;&#x2217;<italic>p</italic>&#x20;&#x3c; 0.01; no labeling indicates no statistical significance.</p>
</caption>
<graphic xlink:href="fcell-10-799042-g004.tif"/>
</fig>
<p>Additionally, to confirm whether the antioxidative effect of MiH was through inhibition of PARP1, we firstly explored the level of PAR in the expanded blastocysts. As shown in <xref ref-type="fig" rid="F5">Figures 5A,B</xref>, we found that H2O2 exposure induced nucleic localization signal of PAR. But in H2O2&#x2b;MiH and H2O2&#x2b;Ola groups, almost no signal was found in blastocysts, which was consistent with that in all non-treated groups. Combined with the data that no PAR signal emerged in H2O2-untreated groups, we indicated that MiH and Ola would inhibit PARP1 overactivation which was induced by H2O2 treatment. Then, we used N-acetyle-cysteine (NAC), a conventional antioxidant for ROS inhibition, as a positive control to investigate whether MiH could decrease ROS level in H2O2-treated embryos like NAC did. These results showed that H2O2 treatment increased ROS signal in embryos, but both PARP1 inhibitors and NAC supplementation could recover the ROS level (<xref ref-type="fig" rid="F5">Figures&#x20;5C,D</xref>).</p>
<fig id="F5" position="float">
<label>FIGURE 5</label>
<caption>
<p>PARP1 inhibitors could protect mouse embryos from ROS and reduced cell apoptosis. <bold>(A,B)</bold> Staining and intensity levels for PAR of expanded blastocysts in untreated and H2O2-treated groups supplemented MiH, Ola or not. <bold>(C,D)</bold> Fluorescent images and intensity levels of ROS in expanded blastocysts. <bold>(E,F)</bold> Representative fluorescent images of apoptotic cells <bold>(E)</bold> and quantitative analysis of TUNEL-positive blastocysts <bold>(F)</bold>. Data are presented as mean&#x20;&#xb1; SD in three independent experiments and student&#x2019;s t&#x20;tests are used for statistical analysis. &#x2217;0.01&#x3c;<italic>p</italic>&#x20;&#x3c; 0.05; &#x2217;&#x2217;<italic>p</italic>&#x20;&#x3c; 0.01; no labeling indicates no statistical significance. Bars &#x3d; 50&#xa0;&#x3bc;m.</p>
</caption>
<graphic xlink:href="fcell-10-799042-g005.tif"/>
</fig>
<p>A TUNEL assay was also performed to establish whether MiH reduced apoptosis rate in blastocysts developed from H2O2-treated zygotes. As expected, H2O2 caused severe apoptosis in embryos in comparison with those in non-treated ones, however, blastocysts in H2O2&#x2b;MiH and H2O2&#x2b;Ola groups possessed much fewer apoptotic cells than those in H2O2 group, suggesting a protective role of MiH against apoptosis in embryonic development (<xref ref-type="fig" rid="F5">Figures&#x20;5E,F</xref>).</p>
</sec>
</sec>
<sec sec-type="discussion" id="s4">
<title>Discussion</title>
<p>It is well-established that though lots of technical advances have been achieved in the administration of <italic>in&#x20;vitro</italic> fertilization (IVF) to infertile couples, embryo quality is still a major contributing factor to the outcomes of IVF cycles (<xref ref-type="bibr" rid="B45">Moragianni et&#x20;al., 2019</xref>). During IVF, the development of human preimplantation embryos progresses in an artificial environment and is tightly controlled by extrinsic factors during inevitable processes of handling, manipulation and culture of gametes and embryos. Clinical data collected in recent years suggested that embryo culture impaired embryonic developmental potential including delaying cell cycle kinetics and reducing trophectoderm cells (TE) in blastocysts (<xref ref-type="bibr" rid="B30">Giritharan et&#x20;al., 2007</xref>). As the trophoblastic cells develop into placenta, decrease of trophectoderm cell number may partly explain why <italic>in&#x20;vitro</italic> cultured animals&#x2019; embryos exhibit impaired placental development and function, and thus fetal growth (<xref ref-type="bibr" rid="B10">Bloise et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B16">Chen et&#x20;al., 2015</xref>; <xref ref-type="bibr" rid="B70">Tan et&#x20;al., 2016</xref>). <xref ref-type="bibr" rid="B17">Chen et&#x20;al. (2019)</xref> also showed that mouse blastocysts which were cultured <italic>in&#x20;vitro</italic> after fertilization had fewer numbers of total cells, TE cells and ICM cells than those developed <italic>in vivo</italic>. In order to mimic the evitable and frequent removal from the incubator for assessment in clinical IVF laboratories, we placed zygotes on a hot-stage microscope for 1&#xa0;h and cultured them in traditional KSOM embryonic culture medium in incubator (IVE) till 100&#xa0;h. This would induce a lot of external factors such as light, temperature, reduced oxygen tension and pH fluctuation of culture medium that contributed to the outcome of embryonic development. Consistently with these aforementioned reports, no more than 80% of IVE embryos formed blastocyst and none implanted in the transplantation assay (<xref ref-type="sec" rid="s11">Supplementary Figure S6</xref>), with reduction in total cells, TE&#xa0;cells and ICM cells as well (<xref ref-type="sec" rid="s11">Supplementary Figures S3A&#x2013;C</xref>, <xref ref-type="sec" rid="s11">Supplementary Figures S3E&#x2013;G</xref>, <xref ref-type="sec" rid="s11">Supplementary Figures S5C&#x2013;E</xref>). Though average OCT4 positive cell numbers of IVE embryos did not decrease when being compared with those of MiH-treated ones, they varied a lot among each blastocyst (<xref ref-type="fig" rid="F3">Figure&#x20;3G</xref>). In this procedure, the accumulation of ROS was trigged (<xref ref-type="fig" rid="F3">Figures 3I,K</xref>) in IVE embryos, suggested that this long-term exposure to external environment might impair embryonic developmental potential through oxidative stress.</p>
<p>Among numerous external factors contributing to embryonic development, O2 concentration is important to human embryonic development (<xref ref-type="bibr" rid="B28">Gardner 2008</xref>). Previous studies have shown that oxygen tension is found to range from 2 to 8% in the oviduct and uterus of most mammalian species (<xref ref-type="bibr" rid="B79">Yedwab et&#x20;al., 1976</xref>; <xref ref-type="bibr" rid="B25">Fischer and Bavister 1993</xref>). In addition, numerous studies suggest that embryo development can be improved by culturing embryos under low O2 tension. However, only around 25% of IVF cycles worldwide are performed exclusively under 5% oxygen, with 34% of clinics reporting using 5% oxygen for specific embryonic culture stages. A significant percentage of clinical laboratories are still using atmospheric oxygen concentrations (20%) for the culture of human embryos (<xref ref-type="bibr" rid="B19">Christianson et&#x20;al., 2014</xref>). Besides, unavoidable environmental factors which elevate ROS level are recognized to impair embryonic developmental potential and result in suboptimal pregnancy rates (<xref ref-type="bibr" rid="B1">Agarwal et&#x20;al., 2005a</xref>). In this study, zygotes were exposed to H2O2, which would result in overproduction of ROS (<xref ref-type="fig" rid="F4">Figure&#x20;4A</xref>). In agreement with multiple reports, zygotes in H2O2 group exhibited impaired developmental potential, including developmental delay (<xref ref-type="fig" rid="F4">Figures 4B,C</xref> and <xref ref-type="sec" rid="s11">Supplementary Figure S7</xref>), blastocyst formation efficiency (<xref ref-type="fig" rid="F4">Figures 4D,E</xref>) and cell number decrease (<xref ref-type="fig" rid="F4">Figure&#x20;4F</xref>), whereas the number of apoptotic cells increased (<xref ref-type="fig" rid="F5">Figure&#x20;5E</xref>). Meanwhile, an intracellular accumulation of ROS and PAR was observed (<xref ref-type="fig" rid="F5">Figures 5A&#x2013;D</xref>), reminding a relationship between oxidative stress and&#x20;PAR.</p>
<p>Indeed, in response to high glucose exposure <italic>in&#x20;vitro</italic> or diabetes and hyperglycemia <italic>in vivo</italic>, ROS generation occurs and promotes the formation of large amount of DNA single-strand breakages which trigger rapid over-activation of PARP1 and lead to inflammation, apoptotic and necrotic cell death (Ansley D M et&#x20;al., 2012). PARP1 in turn depletes the intracellular concentration of its substrate, NAD&#x2b;, slowing the rate of glycolysis, electron transport, and ATP formation. In addition to the direct cytotoxic pathway regulated by DNA injury and PARP1 activation, PARP1 also appears to modulate the course of inflammation by regulating the activation of NF-&#x3ba;B (<xref ref-type="bibr" rid="B24">Du et&#x20;al., 2003</xref>). PARP1 overexpression was also shown to be involved in heart failure (<xref ref-type="bibr" rid="B76">Xiao et&#x20;al., 2005</xref>).It had been reported that heart dysfunction was associated with an increase in poly (ADP-ribosyl)ation in mouse and rat models of diabetes (<xref ref-type="bibr" rid="B53">Pacher et&#x20;al., 2002</xref>). Genetic deletion or pharmacological PARP1 inhibition was shown to protect diabetic heart and ameliorates metabolic dysfunction (<xref ref-type="bibr" rid="B53">Pacher et&#x20;al., 2002</xref>; <xref ref-type="bibr" rid="B56">Qin et&#x20;al., 2016</xref>; <xref ref-type="bibr" rid="B80">Zakaria et&#x20;al., 2016</xref>). For example, INO1001, a highly potent PARP1 inhibitor, could prevent oxidative stress and improve nephropathy in diabetic mice (<xref ref-type="bibr" rid="B68">Szabo et&#x20;al., 2006</xref>) and relieve aging-associated cardiac and vascular dysfunction (<xref ref-type="bibr" rid="B57">Radovits et&#x20;al., 2007</xref>). In current study, H2O2 treatment boosted super activation of PARP1 with robust accumulation of ROS while that in PARP1&#x20;inhibitors-treated embryos (MiH&#x2b;H2O2) recovered to normal level (<xref ref-type="fig" rid="F5">Figure&#x20;5D</xref>). Moreover, blastocyst formation efficiencies of H2O2-treated zygotes were all much lower than those of non-treated groups (<xref ref-type="fig" rid="F4">Figures 4B,D</xref>) at 85&#xa0;h, while that of H2O2&#x2b;MiH group recovered to the similar level of control group at 100&#xa0;h (<xref ref-type="fig" rid="F4">Figures 4B,E</xref>). These were in line with the aforementioned reports (<xref ref-type="bibr" rid="B68">Szabo et&#x20;al., 2006</xref>; <xref ref-type="bibr" rid="B57">Radovits et&#x20;al., 2007</xref>), indicating that PARP1 inhibitors could protect preimplantation embryos from oxidative stress through preventing PARP1 overexpression. Studies have shown that high level of ROS has adverse effects on the quality of oocyte and embryo growth. Besides, embryos are highly sensitive to environmental variables or oxidant levels. As mentioned in a number of reports, under different stress conditions, massive DNA damage can lead to excessive activation of PARP1 (<xref ref-type="bibr" rid="B60">Rodriguez-Vargas et&#x20;al., 2012</xref>; <xref ref-type="bibr" rid="B20">Cieslik et&#x20;al., 2013</xref>), which has been previously proposed being crucial to neuronal death through mechanisms linked to NAD depletion and release of apoptosis inducing factor from the mitochondria (<xref ref-type="bibr" rid="B4">Alano et&#x20;al., 2006</xref>). PARP1 activity rapidly increases, thus leading to the formation of long-chain poly (ADP-ribose) (PAR) (<xref ref-type="bibr" rid="B62">Schreiber et&#x20;al., 2006</xref>). In our experiments, we found that both MiH and Ola could significantly reduce the fluorescence intensity of PAR in H2O2 treated blastocysts (<xref ref-type="fig" rid="F5">Figures 5A,B</xref>). Furthermore, TUNEL results showed that MiH, as well as Ola, could reduce apoptosis of blastocysts after H2O2 exposure (<xref ref-type="fig" rid="F5">Figure&#x20;5E</xref>). All the results suggested PARP1 inhibitors, including MiH and Ola, which might act as an antioxidant property, attenuates oxidative damage by directly inhibiting PARP1 activity. These results suggest a mechanism by which MiH might improve efficiency of IVF techniques.</p>
<p>Several works have proven that supplementation of various antioxidants in culture medium can release ROS accumulation. Enzymatic and synthetic antioxidants are the main defense factors against ROS (<xref ref-type="bibr" rid="B63">Sikka et&#x20;al., 1995</xref>). The former includes catalase (CAT), glutathione peroxidase (GPx), glutathione reductase (GSR), superoxide dismutase (SOD) and peroxiredoxins, while the latter, which is also known as natural dietary supplements and widely distributed in food, consisting of vitamins and minerals (<xref ref-type="bibr" rid="B2">Agarwal et&#x20;al., 2005b</xref>; <xref ref-type="bibr" rid="B77">Xu et&#x20;al., 2017</xref>; <xref ref-type="bibr" rid="B42">Lu et&#x20;al., 2018</xref>). Although numerous studies have reported the effects of individual antioxidants on embryo development (<xref ref-type="bibr" rid="B27">Fujitani et&#x20;al., 1997</xref>; <xref ref-type="bibr" rid="B5">Ali et&#x20;al., 2003</xref>; <xref ref-type="bibr" rid="B37">Kitagawa et&#x20;al., 2004</xref>; <xref ref-type="bibr" rid="B18">Choe et&#x20;al., 2010</xref>; <xref ref-type="bibr" rid="B64">Silva et&#x20;al., 2015</xref>), it seems that none of the available ones can fully mimic the physiological conditions of the female tract (<xref ref-type="bibr" rid="B6">Aviles et&#x20;al., 2010</xref>). This study was the first to propose PARP1 inhibitors as novel anti-oxidative supplementations for culture of preimplantation embryos.</p>
<p>In mouse embryos cultured under normal physical condition, PARP1 is transiently upregulated by fertilization. Though decreases at late 1-cell stage, it maintains until blastocyst stage. Meanwhile, PAR polymer is present in all stages of pre-implantation development (<xref ref-type="bibr" rid="B34">Imamura et&#x20;al., 2004</xref>). Previous reports have shown that PJ-34 and 5-AIQ, two PARP inhibitors, could block first cell cycle of mouse embryos while the dose were as high as 30&#xa0;uM and 20&#xa0;uM separately (<xref ref-type="bibr" rid="B52">Osada et&#x20;al., 2010</xref>). However, these were inconsistent with a study using 3-ABA, another commonly used enzymatic inhibitor, in which 5&#xa0;mM 3-ABA accelerated pronuclear formation but arrested embryonic development before compaction, meanwhile only 64% of untreated ones reached blastocyst stage (<xref ref-type="bibr" rid="B34">Imamura et&#x20;al., 2004</xref>). In current study, all of the three inhibitors we used here were much specific against PARP1 and did not impair the final blastocyst formation potential (<xref ref-type="fig" rid="F1">Figure&#x20;1D</xref>, <xref ref-type="fig" rid="F2">Figure&#x20;2D</xref>), which was inconsistent with former reports. This perhaps could be attributed to inappropriate does and different side effects among inhibitors. The data that mice carrying a double <italic>Parp-1/Parp-2</italic> mutation die at the onset of gastrulation (<xref ref-type="bibr" rid="B43">Menissier de Murcia et&#x20;al., 2003</xref>) supports that specific inhibitor of PARP1 would not disrupt development of mouse preimplantation embryos.</p>
<p>Collectively, the supplementation of low concentrations of PARP1 inhibitors plays dual roles in mouse embryonic development process. When embryos were cultured in normal physical condition, they only slowed down developmental kinetics of embryos during cleavage stage without disturbing their final ending. Noteworthy, PARP1 inhibitors would improve mouse zygotes developmental potential against suboptimal environment, paving the way for more in-depth studies on deciphering the multiple molecular mechanisms behind embryonic development that could be useful in assisted reproductive technology.</p>
</sec>
</body>
<back>
<sec id="s5">
<title>Data Availability Statement</title>
<p>The original contributions presented in the study are included in the article/<xref ref-type="sec" rid="s11">Supplementary Material</xref>, further inquiries can be directed to the corresponding author.</p>
</sec>
<sec id="s6">
<title>Ethics Statement</title>
<p>The animal study was reviewed and approved by the Animal Care and Use Committee of Nanjing Medical University.</p>
</sec>
<sec id="s7">
<title>Author Contributions</title>
<p>XH designed and performed the experiments and wrote the manuscript. CC performed the experiments and helped revise the manuscript. YH performed the experiments and analyzed data. SA performed the experiments and edited the manuscript. SZ performed the experiments and edited the manuscript. HS performed the experiments and edited the manuscript. YY conceived, designed and supervised the experiments, and revised the manuscript.</p>
</sec>
<sec id="s8">
<title>Funding</title>
<p>This work was supported by the National Natural Science Foundation of China (No. 31801205, 32070804, 32100681), and Jiangsu Provincial Program of Innovation and Entrepreneurship, China (No. (2020)10527). This work also received financial supports from the Six Talent Peaks Project in Jiangsu Province, China (No. WSW-035); China Postdoctoral Science Foundation (No. 2019M661890, 2019M651894).</p>
</sec>
<sec sec-type="COI-statement" id="s9">
<title>Conflict of Interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="disclaimer" id="s10">
<title>Publisher&#x2019;s Note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="s11">
<title>Supplementary Material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fcell.2022.799042/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fcell.2022.799042/full&#x23;supplementary-material</ext-link>
</p>
<supplementary-material xlink:href="DataSheet1.docx" id="SM1" mimetype="application/docx" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R.</given-names>
</name>
</person-group> (<year>2005a</year>). <article-title>Oxidative Stress and its Implications in Female Infertility - a Clinician&#x27;s Perspective</article-title>. <source>Reprod. BioMed. Online</source> <volume>11</volume>, <fpage>641</fpage>&#x2013;<lpage>650</lpage>. <pub-id pub-id-type="doi">10.1016/s1472-6483(10)61174-1</pub-id> </citation>
</ref>
<ref id="B2">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Agarwal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gupta</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sharma</surname>
<given-names>R. K.</given-names>
</name>
</person-group> (<year>2005b</year>). <article-title>Role of Oxidative Stress in Female Reproduction</article-title>. <source>Reprod. Biol. Endocrinol.</source> <volume>3</volume>, <fpage>28</fpage>. <pub-id pub-id-type="doi">10.1186/1477-7827-3-28</pub-id> </citation>
</ref>
<ref id="B3">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ahmad</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Vieira</surname>
<given-names>J.&#x20;d. C.</given-names>
</name>
<name>
<surname>de Mello</surname>
<given-names>A. H.</given-names>
</name>
<name>
<surname>de Lima</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Ariga</surname>
<given-names>S. K.</given-names>
</name>
<name>
<surname>Barbeiro</surname>
<given-names>D. F.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>The PARP Inhibitor Olaparib Exerts Beneficial Effects in Mice Subjected to Cecal Ligature and Puncture and in Cells Subjected to Oxidative Stress without Impairing DNA Integrity: A Potential Opportunity for Repurposing a Clinically Used Oncological Drug for the Experimental Therapy of Sepsis</article-title>. <source>Pharmacol. Res.</source> <volume>145</volume>, <fpage>104263</fpage>. <pub-id pub-id-type="doi">10.1016/j.phrs.2019.104263</pub-id> </citation>
</ref>
<ref id="B4">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Alano</surname>
<given-names>C. C.</given-names>
</name>
<name>
<surname>Kauppinen</surname>
<given-names>T. M.</given-names>
</name>
<name>
<surname>Valls</surname>
<given-names>A. V.</given-names>
</name>
<name>
<surname>Swanson</surname>
<given-names>R. A.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Minocycline Inhibits poly(ADP-Ribose) Polymerase-1 at Nanomolar Concentrations</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>103</volume>, <fpage>9685</fpage>&#x2013;<lpage>9690</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0600554103</pub-id> </citation>
</ref>
<ref id="B5">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ali</surname>
<given-names>A. A.</given-names>
</name>
<name>
<surname>Bilodeau</surname>
<given-names>J.&#x20;F.</given-names>
</name>
<name>
<surname>Sirard</surname>
<given-names>M. A.</given-names>
</name>
</person-group> (<year>2003</year>). <article-title>Antioxidant Requirements for Bovine Oocytes Varies during <italic>In Vitro</italic> Maturation, Fertilization and Development</article-title>. <source>Theriogenology</source> <volume>59</volume>, <fpage>939</fpage>&#x2013;<lpage>949</lpage>. <pub-id pub-id-type="doi">10.1016/s0093-691x(02)01125-1</pub-id> </citation>
</ref>
<ref id="B6">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Avil&#xe9;s</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Guti&#xe9;rrez-Ad&#xe1;n</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Coy</surname>
<given-names>P.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Oviductal Secretions: Will They Be Key Factors for the Future ARTs?</article-title> <source>Mol. Hum. Reprod.</source> <volume>16</volume>, <fpage>896</fpage>&#x2013;<lpage>906</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gaq056</pub-id> </citation>
</ref>
<ref id="B7">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Baker</surname>
<given-names>C. L.</given-names>
</name>
<name>
<surname>Pera</surname>
<given-names>M. F.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>Capturing Totipotent Stem Cells</article-title>. <source>Cel. Stem Cel.</source> <volume>22</volume>, <fpage>25</fpage>&#x2013;<lpage>34</lpage>. <pub-id pub-id-type="doi">10.1016/j.stem.2017.12.011</pub-id> </citation>
</ref>
<ref id="B8">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bartha</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Solti</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Kereskai</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Lantos</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Plozer</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Magyar</surname>
<given-names>K.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>PARP Inhibition Delays Transition of Hypertensive Cardiopathy to Heart Failure in Spontaneously Hypertensive Rats</article-title>. <source>Cardiovasc. Res.</source> <volume>83</volume>, <fpage>501</fpage>&#x2013;<lpage>510</lpage>. <pub-id pub-id-type="doi">10.1093/cvr/cvp144</pub-id> </citation>
</ref>
<ref id="B9">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bedzhov</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Leung</surname>
<given-names>C. Y.</given-names>
</name>
<name>
<surname>Bialecka</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zernicka-Goetz</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>
<italic>In Vitro</italic> culture of Mouse Blastocysts beyond the Implantation Stages</article-title>. <source>Nat. Protoc.</source> <volume>9</volume> (<issue>12</issue>), <fpage>2732</fpage>&#x2013;<lpage>2739</lpage>. <pub-id pub-id-type="doi">10.1038/nprot.2014.186</pub-id> </citation>
</ref>
<ref id="B10">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Bloise</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Lin</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Simbulan</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kolahi</surname>
<given-names>K. S.</given-names>
</name>
<name>
<surname>Petraglia</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Impaired Placental Nutrient Transport in Mice Generated by <italic>In Vitro</italic> Fertilization</article-title>. <source>Endocrinology</source> <volume>153</volume>, <fpage>3457</fpage>&#x2013;<lpage>3467</lpage>. <pub-id pub-id-type="doi">10.1210/en.2011-1921</pub-id> </citation>
</ref>
<ref id="B11">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Boroviak</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Loos</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Bertone</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Nichols</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2014</year>). <article-title>The Ability of Inner-Cell-Mass Cells to Self-Renew as Embryonic Stem Cells Is Acquired Following Epiblast Specification</article-title>. <source>Nat. Cel. Biol.</source> <volume>16</volume>, <fpage>513</fpage>&#x2013;<lpage>525</lpage>. <pub-id pub-id-type="doi">10.1038/ncb2965</pub-id> </citation>
</ref>
<ref id="B12">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>B&#xfc;rkle</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Poly(APD-ribosyl)ation, a DNA Damage-Driven Protein Modification and Regulator of Genomic Instability</article-title>. <source>Cancer Lett.</source> <volume>163</volume>, <fpage>1</fpage>&#x2013;<lpage>5</lpage>. <pub-id pub-id-type="doi">10.1016/s0304-3835(00)00694-7</pub-id> </citation>
</ref>
<ref id="B13">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Caiafa</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Guastafierro</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zampieri</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Epigenetics: poly(ADP&#x2010;ribosyl)ation of PARP&#x2010;1 Regulates Genomic Methylation Patterns</article-title>. <source>FASEB j.</source> <volume>23</volume>, <fpage>672</fpage>&#x2013;<lpage>678</lpage>. <pub-id pub-id-type="doi">10.1096/fj.08-123265</pub-id> </citation>
</ref>
<ref id="B14">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chazaud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>Lineage Specification in the Mouse Preimplantation Embryo</article-title>. <source>Development</source> <volume>143</volume>, <fpage>1063</fpage>&#x2013;<lpage>1074</lpage>. <pub-id pub-id-type="doi">10.1242/dev.128314</pub-id> </citation>
</ref>
<ref id="B15">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chazaud</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Pawson</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Rossant</surname>
<given-names>J.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Early Lineage Segregation between Epiblast and Primitive Endoderm in Mouse Blastocysts through the Grb2-MAPK Pathway</article-title>. <source>Dev. Cel.</source> <volume>10</volume>, <fpage>615</fpage>&#x2013;<lpage>624</lpage>. <pub-id pub-id-type="doi">10.1016/j.devcel.2006.02.020</pub-id> </citation>
</ref>
<ref id="B16">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Sun</surname>
<given-names>F.-z.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Tang</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Zhu</surname>
<given-names>B.</given-names>
</name>
<etal/>
</person-group> (<year>2015</year>). <article-title>Assisted Reproduction Causes Placental Maldevelopment and Dysfunction Linked to Reduced Fetal Weight in Mice</article-title>. <source>Sci. Rep.</source> <volume>5</volume>, <fpage>10596</fpage>. <pub-id pub-id-type="doi">10.1038/srep10596</pub-id> </citation>
</ref>
<ref id="B17">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Wong</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>L. L.</given-names>
</name>
<name>
<surname>Gordon</surname>
<given-names>Y. E.</given-names>
</name>
<name>
<surname>Heilbronn</surname>
<given-names>L. K.</given-names>
</name>
<name>
<surname>Robker</surname>
<given-names>R. L.</given-names>
</name>
</person-group> (<year>2019</year>). <article-title>Differential Impacts of Gonadotrophins, IVF and Embryo Culture on Mouse Blastocyst Development</article-title>. <source>Reprod. BioMed. Online</source> <volume>39</volume>, <fpage>372</fpage>&#x2013;<lpage>382</lpage>. <pub-id pub-id-type="doi">10.1016/j.rbmo.2019.02.007</pub-id> </citation>
</ref>
<ref id="B18">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Choe</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Shin</surname>
<given-names>Y.-W.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>E.-J.</given-names>
</name>
<name>
<surname>Cho</surname>
<given-names>S.-R.</given-names>
</name>
<name>
<surname>Kim</surname>
<given-names>H.-J.</given-names>
</name>
<name>
<surname>Choi</surname>
<given-names>S.-H.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Synergistic Effects of Glutathione and .BETA.-Mercaptoethanol Treatment during <italic>In Vitro</italic> Maturation of Porcine Oocytes on Early Embryonic Development in a Culture System Supplemented with L-Cysteine</article-title>. <source>J.&#x20;Reprod. Dev.</source> <volume>56</volume>, <fpage>575</fpage>&#x2013;<lpage>582</lpage>. <pub-id pub-id-type="doi">10.1262/jrd.09-214h</pub-id> </citation>
</ref>
<ref id="B19">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Christianson</surname>
<given-names>M. S.</given-names>
</name>
<name>
<surname>Zhao</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shoham</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Granot</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Safran</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Khafagy</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Embryo Catheter Loading and Embryo Culture Techniques: Results of a Worldwide Web-Based Survey</article-title>. <source>J.&#x20;Assist. Reprod. Genet.</source> <volume>31</volume>, <fpage>1029</fpage>&#x2013;<lpage>1036</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-014-0250-z</pub-id> </citation>
</ref>
<ref id="B20">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cieslik</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Pyszko</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Strosznajder</surname>
<given-names>J.&#x20;B.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Docosahexaenoic Acid and Tetracyclines as Promising Neuroprotective Compounds with poly(ADP-Ribose) Polymerase Inhibitory Activities for Oxidative/genotoxic Stress Treatment</article-title>. <source>Neurochem. Int.</source> <volume>62</volume>, <fpage>626</fpage>&#x2013;<lpage>636</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuint.2013.02.016</pub-id> </citation>
</ref>
<ref id="B21">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Ciray</surname>
<given-names>H. N.</given-names>
</name>
<name>
<surname>Aksoy</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Yaramanci</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Karayaka</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Bahceci</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>
<italic>In Vitro</italic> culture under Physiologic Oxygen Concentration Improves Blastocyst Yield and Quality: a Prospective Randomized Survey on Sibling Oocytes</article-title>. <source>Fertil. Steril.</source> <volume>91</volume>, <fpage>1459</fpage>&#x2013;<lpage>1461</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.07.1707</pub-id> </citation>
</ref>
<ref id="B22">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Cohen-Armon</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>PARP-1 Activation in the ERK Signaling Pathway</article-title>. <source>Trends Pharmacol. Sci.</source> <volume>28</volume>, <fpage>556</fpage>&#x2013;<lpage>560</lpage>. <pub-id pub-id-type="doi">10.1016/j.tips.2007.08.005</pub-id> </citation>
</ref>
<ref id="B23">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Curtin</surname>
<given-names>N. J.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>Inhibiting the DNA Damage Response as a Therapeutic Manoeuvre in Cancer</article-title>. <source>Br. J.&#x20;Pharmacol.</source> <volume>169</volume>, <fpage>1745</fpage>&#x2013;<lpage>1765</lpage>. <pub-id pub-id-type="doi">10.1111/bph.12244</pub-id> </citation>
</ref>
<ref id="B24">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Du</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Matsumura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Edelstein</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Rossetti</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Zsengell&#xe9;r</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Szab&#xf3;</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Inhibition of GAPDH Activity by poly(ADP-Ribose) Polymerase Activates Three Major Pathways of Hyperglycemic Damage in Endothelial Cells</article-title>. <source>J.&#x20;Clin. Invest.</source> <volume>112</volume>, <fpage>1049</fpage>&#x2013;<lpage>1057</lpage>. <pub-id pub-id-type="doi">10.1172/JCI18127</pub-id> </citation>
</ref>
<ref id="B25">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fischer</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Bavister</surname>
<given-names>B. D.</given-names>
</name>
</person-group> (<year>1993</year>). <article-title>Oxygen Tension in the Oviduct and Uterus of Rhesus Monkeys, Hamsters and Rabbits</article-title>. <source>Reproduction</source> <volume>99</volume>, <fpage>673</fpage>&#x2013;<lpage>679</lpage>. <pub-id pub-id-type="doi">10.1530/jrf.0.0990673</pub-id> </citation>
</ref>
<ref id="B26">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fleming</surname>
<given-names>T. P.</given-names>
</name>
</person-group> (<year>1987</year>). <article-title>A Quantitative Analysis of Cell Allocation to Trophectoderm and Inner Cell Mass in the Mouse Blastocyst</article-title>. <source>Dev. Biol.</source> <volume>119</volume>, <fpage>520</fpage>&#x2013;<lpage>531</lpage>. <pub-id pub-id-type="doi">10.1016/0012-1606(87)90055-8</pub-id> </citation>
</ref>
<ref id="B27">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Fujitani</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Kasai</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ohtani</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nishimura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yamada</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Utsumi</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Effect of Oxygen Concentration and Free Radicals on <italic>In Vitro</italic> Development of In Vitro-produced Bovine Embryos</article-title>. <source>J.&#x20;Anim. Sci.</source> <volume>75</volume>, <fpage>483</fpage>&#x2013;<lpage>489</lpage>. <pub-id pub-id-type="doi">10.2527/1997.752483x</pub-id> </citation>
</ref>
<ref id="B28">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gardner</surname>
<given-names>D. K.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Dissection of Culture media for Embryos: the Most Important and Less Important Components and Characteristics</article-title>. <source>Reprod. Fertil. Dev.</source> <volume>20</volume>, <fpage>9</fpage>&#x2013;<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1071/rd07160</pub-id> </citation>
</ref>
<ref id="B29">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Gibson</surname>
<given-names>B. A.</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>W. L.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>New Insights into the Molecular and Cellular Functions of poly(ADP-Ribose) and PARPs</article-title>. <source>Nat. Rev. Mol. Cel. Biol.</source> <volume>13</volume>, <fpage>411</fpage>&#x2013;<lpage>424</lpage>. <pub-id pub-id-type="doi">10.1038/nrm3376</pub-id> </citation>
</ref>
<ref id="B30">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Giritharan</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Talbi</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Donjacour</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Di Sebastiano</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Dobson</surname>
<given-names>A. T.</given-names>
</name>
<name>
<surname>Rinaudo</surname>
<given-names>P. F.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Effect of <italic>In Vitro</italic> Fertilization on Gene Expression and Development of Mouse Preimplantation Embryos</article-title>. <source>Reproduction</source> <volume>134</volume>, <fpage>63</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1530/REP-06-0247</pub-id> </citation>
</ref>
<ref id="B31">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Guerin</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>El Mouatassim</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Menezo</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2001</year>). <article-title>Oxidative Stress and protection against Reactive Oxygen Species in the Pre-implantation Embryo and its Surroundings</article-title>. <source>Hum. Reprod. Update</source> <volume>7</volume>, <fpage>175</fpage>&#x2013;<lpage>189</lpage>. <pub-id pub-id-type="doi">10.1093/humupd/7.2.175</pub-id> </citation>
</ref>
<ref id="B32">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hassa</surname>
<given-names>P. O.</given-names>
</name>
<name>
<surname>Hottiger</surname>
<given-names>M. O.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The Functional Role of poly(ADP-Ribose)polymerase 1 as Novel Coactivator of NF-&#x3ba;B in Inflammatory Disorders</article-title>. <source>Cmls, Cel. Mol. Life Sci.</source> <volume>59</volume>, <fpage>1534</fpage>&#x2013;<lpage>1553</lpage>. <pub-id pub-id-type="doi">10.1007/s00018-002-8527-2</pub-id> </citation>
</ref>
<ref id="B33">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Hinz</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Stilmann</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Arslan</surname>
<given-names>S. &#xc7;.</given-names>
</name>
<name>
<surname>Khanna</surname>
<given-names>K. K.</given-names>
</name>
<name>
<surname>Dittmar</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Scheidereit</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>A Cytoplasmic ATM-TRAF6-cIAP1 Module Links Nuclear DNA Damage Signaling to Ubiquitin-Mediated NF-&#x3ba;B Activation</article-title>. <source>Mol. Cel.</source> <volume>40</volume>, <fpage>63</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1016/j.molcel.2010.09.008</pub-id> </citation>
</ref>
<ref id="B34">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Imamura</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Neildez</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Thenevin</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Paldi</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Essential Role for Poly (ADP-Ribosyl)ation in Mouse Preimplantation Development</article-title>. <source>BMC Mol. Biol.</source> <volume>5</volume>, <fpage>4</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2199-5-4</pub-id> </citation>
</ref>
<ref id="B35">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Johnson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Ziomek</surname>
<given-names>C. A.</given-names>
</name>
</person-group> (<year>1981</year>). <article-title>The Foundation of Two Distinct Cell Lineages within the Mouse Morula</article-title>. <source>Cell</source> <volume>24</volume>, <fpage>71</fpage>&#x2013;<lpage>80</lpage>. <pub-id pub-id-type="doi">10.1016/0092-8674(81)90502-x</pub-id> </citation>
</ref>
<ref id="B36">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kanai</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tong</surname>
<given-names>W.-M.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.-Q.</given-names>
</name>
<name>
<surname>Miwa</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Haploinsufficiency of poly(ADP-Ribose) Polymerase-1-Mediated poly(ADP-Ribosyl)ation for Centrosome Duplication</article-title>. <source>Biochem. Biophys. Res. Commun.</source> <volume>359</volume>, <fpage>426</fpage>&#x2013;<lpage>430</lpage>. <pub-id pub-id-type="doi">10.1016/j.bbrc.2007.05.108</pub-id> </citation>
</ref>
<ref id="B37">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kitagawa</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Suzuki</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yoneda</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Watanabe</surname>
<given-names>T.</given-names>
</name>
</person-group> (<year>2004</year>). <article-title>Effects of Oxygen Concentration and Antioxidants on the <italic>In Vitro</italic> Developmental Ability, Production of Reactive Oxygen Species (ROS), and DNA Fragmentation in Porcine Embryos</article-title>. <source>Theriogenology</source> <volume>62</volume>, <fpage>1186</fpage>&#x2013;<lpage>1197</lpage>. <pub-id pub-id-type="doi">10.1016/j.theriogenology.2004.01.011</pub-id> </citation>
</ref>
<ref id="B38">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kovacic</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Vlaisavljevi&#x107;</surname>
<given-names>V.</given-names>
</name>
</person-group> (<year>2008</year>). <article-title>Influence of Atmospheric versus Reduced Oxygen Concentration on Development of Human Blastocysts <italic>In Vitro</italic>: a Prospective Study on Sibling Oocytes</article-title>. <source>Reprod. Biomed. Online</source> <volume>17</volume>, <fpage>229</fpage>&#x2013;<lpage>236</lpage>. <pub-id pub-id-type="doi">10.1016/s1472-6483(10)60199-x</pub-id> </citation>
</ref>
<ref id="B39">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Kraus</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Hottiger</surname>
<given-names>M. O.</given-names>
</name>
</person-group> (<year>2013</year>). <article-title>PARP-1 and Gene Regulation: Progress and Puzzles</article-title>. <source>Mol. Aspects Med.</source> <volume>34</volume>, <fpage>1109</fpage>&#x2013;<lpage>1123</lpage>. <pub-id pub-id-type="doi">10.1016/j.mam.2013.01.005</pub-id> </citation>
</ref>
<ref id="B40">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Litton</surname>
<given-names>J.&#x20;K.</given-names>
</name>
<name>
<surname>Rugo</surname>
<given-names>H. S.</given-names>
</name>
<name>
<surname>Ettl</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Hurvitz</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Gon&#xe7;alves</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Lee</surname>
<given-names>K.-H.</given-names>
</name>
<etal/>
</person-group> (<year>2018</year>). <article-title>Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>379</volume>, <fpage>753</fpage>&#x2013;<lpage>763</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1802905</pub-id> </citation>
</ref>
<ref id="B41">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Liu</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Trimarchi</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Keefe</surname>
<given-names>D. L.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Involvement of Mitochondria in Oxidative Stress-Induced Cell Death in Mouse Zygotes1</article-title>. <source>Biol. Reprod.</source> <volume>62</volume>, <fpage>1745</fpage>&#x2013;<lpage>1753</lpage>. <pub-id pub-id-type="doi">10.1095/biolreprod62.6.1745</pub-id> </citation>
</ref>
<ref id="B42">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Lu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Cao</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Dong</surname>
<given-names>Y.</given-names>
</name>
</person-group> (<year>2018</year>). <article-title>A Novel and Compact Review on the Role of Oxidative Stress in Female Reproduction</article-title>. <source>Reprod. Biol. Endocrinol.</source> <volume>16</volume>, <fpage>80</fpage>. <pub-id pub-id-type="doi">10.1186/s12958-018-0391-5</pub-id> </citation>
</ref>
<ref id="B43">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Menissier de Murcia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ricoul</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Tartier</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Niedergang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Huber</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Dantzer</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>Functional Interaction between PARP-1 and PARP-2 in Chromosome Stability and Embryonic Development in Mouse</article-title>. <source>EMBO J.</source> <volume>22</volume>, <fpage>2255</fpage>&#x2013;<lpage>2263</lpage>. <pub-id pub-id-type="doi">10.1093/emboj/cdg206</pub-id> </citation>
</ref>
<ref id="B44">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Mester</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Atlasz</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Szabadfi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Reglodi</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Kiss</surname>
<given-names>P.</given-names>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>Protection against Chronic Hypoperfusion-Induced Retinal Neurodegeneration by PARP Inhibition via Activation of PI-3-Kinase Akt Pathway and Suppression of JNK and P38 MAP Kinases</article-title>. <source>Neurotox Res.</source> <volume>16</volume>, <fpage>68</fpage>&#x2013;<lpage>76</lpage>. <pub-id pub-id-type="doi">10.1007/s12640-009-9049-6</pub-id> </citation>
</ref>
<ref id="B45">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Moragianni</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Dryllis</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Andromidas</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Kapeta-Korkouli</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Kouskouni</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Pessach</surname>
<given-names>I.</given-names>
</name>
<etal/>
</person-group> (<year>2019</year>). <article-title>Genital Tract Infection and Associated Factors Affect the Reproductive Outcome in fertile Females and Females Undergoing <italic>In Vitro</italic> Fertilization</article-title>. <source>Biom Rep.</source> <volume>10</volume>, <fpage>231</fpage>&#x2013;<lpage>237</lpage>. <pub-id pub-id-type="doi">10.3892/br.2019.1194</pub-id> </citation>
</ref>
<ref id="B46">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Morris</surname>
<given-names>S. A.</given-names>
</name>
<name>
<surname>Teo</surname>
<given-names>R. T. Y.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Robson</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Glover</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Zernicka-Goetz</surname>
<given-names>M.</given-names>
</name>
</person-group> (<year>2010</year>). <article-title>Origin and Formation of the First Two Distinct Cell Types of the Inner Cell Mass in the Mouse Embryo</article-title>. <source>Proc. Natl. Acad. Sci.</source> <volume>107</volume>, <fpage>6364</fpage>&#x2013;<lpage>6369</lpage>. <pub-id pub-id-type="doi">10.1073/pnas.0915063107</pub-id> </citation>
</ref>
<ref id="B47">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.-y. N.</given-names>
</name>
<name>
<surname>Das</surname>
<given-names>B. B.</given-names>
</name>
<name>
<surname>Renaud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Doroshow</surname>
<given-names>J.&#x20;H.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors</article-title>. <source>Cancer Res.</source> <volume>72</volume>, <fpage>5588</fpage>&#x2013;<lpage>5599</lpage>. <pub-id pub-id-type="doi">10.1158/0008-5472.CAN-12-2753</pub-id> </citation>
</ref>
<ref id="B48">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Murai</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Huang</surname>
<given-names>S.-Y. N.</given-names>
</name>
<name>
<surname>Renaud</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ji</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Takeda</surname>
<given-names>S.</given-names>
</name>
<etal/>
</person-group> (<year>2014</year>). <article-title>Stereospecific PARP Trapping by BMN 673 and Comparison with Olaparib and Rucaparib</article-title>. <source>Mol. Cancer Ther.</source> <volume>13</volume>, <fpage>433</fpage>&#x2013;<lpage>443</lpage>. <pub-id pub-id-type="doi">10.1158/1535-7163.MCT-13-0803</pub-id> </citation>
</ref>
<ref id="B49">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nichols</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Smith</surname>
<given-names>A.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>Pluripotency in the Embryo and in Culture</article-title>. <source>Cold Spring Harbor Perspect. Biol.</source> <volume>4</volume>, <fpage>a008128</fpage>. <pub-id pub-id-type="doi">10.1101/cshperspect.a008128</pub-id> </citation>
</ref>
<ref id="B50">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Niwa</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Toyooka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Shimosato</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Strumpf</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Takahashi</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yagi</surname>
<given-names>R.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Interaction between Oct3/4 and Cdx2 Determines Trophectoderm Differentiation</article-title>. <source>Cell</source> <volume>123</volume>, <fpage>917</fpage>&#x2013;<lpage>929</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2005.08.040</pub-id> </citation>
</ref>
<ref id="B51">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Nusinow</surname>
<given-names>D. A.</given-names>
</name>
<name>
<surname>Hern&#xe1;ndez-Mu&#xf1;oz</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Fazzio</surname>
<given-names>T. G.</given-names>
</name>
<name>
<surname>Shah</surname>
<given-names>G. M.</given-names>
</name>
<name>
<surname>Kraus</surname>
<given-names>W. L.</given-names>
</name>
<name>
<surname>Panning</surname>
<given-names>B.</given-names>
</name>
</person-group> (<year>2007</year>). <article-title>Poly(ADP-ribose) Polymerase 1 Is Inhibited by a Histone H2A Variant, MacroH2A, and Contributes to Silencing of the Inactive X Chromosome</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>282</volume>, <fpage>12851</fpage>&#x2013;<lpage>12859</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M610502200</pub-id> </citation>
</ref>
<ref id="B52">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Osada</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ogino</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Hino</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Ichinose</surname>
<given-names>S.</given-names>
</name>
<name>
<surname>Nakamura</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Omori</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>PolyADP-ribosylation Is Required for Pronuclear Fusion during Postfertilization in Mice</article-title>. <source>PLoS One</source> <volume>5</volume>, <fpage>e12526</fpage>. <pub-id pub-id-type="doi">10.1371/journal.pone.0012526</pub-id> </citation>
</ref>
<ref id="B53">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pacher</surname>
<given-names>P.</given-names>
</name>
<name>
<surname>Liaudet</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Soriano</surname>
<given-names>F. G.</given-names>
</name>
<name>
<surname>Mabley</surname>
<given-names>J.&#x20;G.</given-names>
</name>
<name>
<surname>Szabo&#x301;</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The Role of poly(ADP-Ribose) Polymerase Activation in the Development of Myocardial and Endothelial Dysfunction in Diabetes</article-title>. <source>Diabetes</source> <volume>51</volume>, <fpage>514</fpage>&#x2013;<lpage>521</lpage>. <pub-id pub-id-type="doi">10.2337/diabetes.51.2.514</pub-id> </citation>
</ref>
<ref id="B54">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Palmieri</surname>
<given-names>S. L.</given-names>
</name>
<name>
<surname>Peter</surname>
<given-names>W.</given-names>
</name>
<name>
<surname>Hess</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Sch&#xf6;ler</surname>
<given-names>H. R.</given-names>
</name>
</person-group> (<year>1994</year>). <article-title>Oct-4 Transcription Factor Is Differentially Expressed in the Mouse Embryo during Establishment of the First Two Extraembryonic Cell Lineages Involved in Implantation</article-title>. <source>Dev. Biol.</source> <volume>166</volume>, <fpage>259</fpage>&#x2013;<lpage>267</lpage>. <pub-id pub-id-type="doi">10.1006/dbio.1994.1312</pub-id> </citation>
</ref>
<ref id="B55">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Pleschke</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Kleczkowska</surname>
<given-names>H. E.</given-names>
</name>
<name>
<surname>Strohm</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Althaus</surname>
<given-names>F. R.</given-names>
</name>
</person-group> (<year>2000</year>). <article-title>Poly(ADP-ribose) Binds to Specific Domains in DNA Damage Checkpoint Proteins</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>275</volume>, <fpage>40974</fpage>&#x2013;<lpage>40980</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M006520200</pub-id> </citation>
</ref>
<ref id="B56">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Qin</surname>
<given-names>W.-d.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>G.-l.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>J.-n.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Poly(ADP-ribose) Polymerase 1 Inhibition Protects Cardiomyocytes from Inflammation and Apoptosis in Diabetic Cardiomyopathy</article-title>. <source>Oncotarget</source> <volume>7</volume>, <fpage>35618</fpage>&#x2013;<lpage>35631</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.8343</pub-id> </citation>
</ref>
<ref id="B57">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Radovits</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Seres</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Ger&#x151;</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Berger</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Szab&#xf3;</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Karck</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2007</year>). <article-title>Single Dose Treatment with PARP-Inhibitor INO-1001 Improves Aging-Associated Cardiac and Vascular Dysfunction</article-title>. <source>Exp. Gerontol.</source> <volume>42</volume>, <fpage>676</fpage>&#x2013;<lpage>685</lpage>. <pub-id pub-id-type="doi">10.1016/j.exger.2007.01.013</pub-id> </citation>
</ref>
<ref id="B58">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Raedschelders</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Ansley</surname>
<given-names>D. M.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>D. D. Y.</given-names>
</name>
</person-group> (<year>2012</year>). <article-title>The Cellular and Molecular Origin of Reactive Oxygen Species Generation during Myocardial Ischemia and Reperfusion</article-title>. <source>Pharmacol. Ther.</source> <volume>133</volume>, <fpage>230</fpage>&#x2013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1016/j.pharmthera.2011.11.004</pub-id> </citation>
</ref>
<ref id="B59">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Robson</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Im</surname>
<given-names>S.-A.</given-names>
</name>
<name>
<surname>Senkus</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Domchek</surname>
<given-names>S. M.</given-names>
</name>
<name>
<surname>Masuda</surname>
<given-names>N.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation</article-title>. <source>N. Engl. J.&#x20;Med.</source> <volume>377</volume>, <fpage>523</fpage>&#x2013;<lpage>533</lpage>. <pub-id pub-id-type="doi">10.1056/NEJMoa1706450</pub-id> </citation>
</ref>
<ref id="B60">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rodr&#xed;guez-Vargas</surname>
<given-names>J.&#x20;M.</given-names>
</name>
<name>
<surname>Ruiz-Maga&#xf1;a</surname>
<given-names>M. J.</given-names>
</name>
<name>
<surname>Ruiz-Ruiz</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Majuelos-Melguizo</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Peralta-Leal</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Rodr&#xed;guez</surname>
<given-names>M. I.</given-names>
</name>
<etal/>
</person-group> (<year>2012</year>). <article-title>ROS-induced DNA Damage and PARP-1 Are Required for Optimal Induction of Starvation-Induced Autophagy</article-title>. <source>Cel. Res.</source> <volume>22</volume>, <fpage>1181</fpage>&#x2013;<lpage>1198</lpage>. <pub-id pub-id-type="doi">10.1038/cr.2012.70</pub-id> </citation>
</ref>
<ref id="B61">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Rolli</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>O&#x27;Farrell</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>M&#xe9;nissier-de Murcia</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>de Murcia</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>1997</year>). <article-title>Random Mutagenesis of the poly(ADP-Ribose) Polymerase Catalytic Domain Reveals Amino Acids Involved in Polymer Branching</article-title>. <source>Biochemistry</source> <volume>36</volume>, <fpage>12147</fpage>&#x2013;<lpage>12154</lpage>. <pub-id pub-id-type="doi">10.1021/bi971055p</pub-id> </citation>
</ref>
<ref id="B62">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Schreiber</surname>
<given-names>V.</given-names>
</name>
<name>
<surname>Dantzer</surname>
<given-names>F.</given-names>
</name>
<name>
<surname>Ame</surname>
<given-names>J.-C.</given-names>
</name>
<name>
<surname>de Murcia</surname>
<given-names>G.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Poly(ADP-ribose): Novel Functions for an Old Molecule</article-title>. <source>Nat. Rev. Mol. Cel. Biol.</source> <volume>7</volume>, <fpage>517</fpage>&#x2013;<lpage>528</lpage>. <pub-id pub-id-type="doi">10.1038/nrm1963</pub-id> </citation>
</ref>
<ref id="B63">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Sikka</surname>
<given-names>S. C.</given-names>
</name>
<name>
<surname>Rajasekaran</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Hellstrom</surname>
<given-names>W. J.</given-names>
</name>
</person-group> (<year>1995</year>). <article-title>Role of Oxidative Stress and Antioxidants in Male Infertility</article-title>. <source>J.&#x20;Androl.</source> <volume>16</volume>, <fpage>464</fpage>&#x2013;<lpage>468</lpage>. </citation>
</ref>
<ref id="B64">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Silva</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Greene</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Strauss</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Herrick</surname>
<given-names>J.&#x20;R.</given-names>
</name>
<name>
<surname>Schoolcraft</surname>
<given-names>W. B.</given-names>
</name>
<name>
<surname>Krisher</surname>
<given-names>R. L.</given-names>
</name>
</person-group> (<year>2015</year>). <article-title>Antioxidant Supplementation during <italic>In Vitro</italic> Culture Improves Mitochondrial Function and Development of Embryos from Aged Female Mice</article-title>. <source>Reprod. Fertil. Dev.</source> <volume>27</volume>, <fpage>975</fpage>&#x2013;<lpage>983</lpage>. <pub-id pub-id-type="doi">10.1071/RD14474</pub-id> </citation>
</ref>
<ref id="B65">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simbulan-Rosenthal</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Samara</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Jung</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Dritschilo</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2001</year>). <article-title>Poly(ADP-ribosyl)ation of P53&#x20;<italic>In Vitro</italic> and <italic>In Vivo</italic> Modulates Binding to its DNA Consensus Sequence</article-title>. <source>Neoplasia</source> <volume>3</volume>, <fpage>179</fpage>&#x2013;<lpage>188</lpage>. <pub-id pub-id-type="doi">10.1038/sj.neo.7900155</pub-id> </citation>
</ref>
<ref id="B66">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Simbulan-Rosenthal</surname>
<given-names>C. M.</given-names>
</name>
<name>
<surname>Rosenthal</surname>
<given-names>D. S.</given-names>
</name>
<name>
<surname>Luo</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Samara</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Espinoza</surname>
<given-names>L. A.</given-names>
</name>
<name>
<surname>Hassa</surname>
<given-names>P. O.</given-names>
</name>
<etal/>
</person-group> (<year>2003</year>). <article-title>PARP-1 Binds E2F-1 Independently of its DNA Binding and Catalytic Domains, and Acts as a Novel Coactivator of E2F-1-Mediated Transcription during Re-entry of Quiescent Cells into S Phase</article-title>. <source>Oncogene</source> <volume>22</volume>, <fpage>8460</fpage>&#x2013;<lpage>8471</lpage>. <pub-id pub-id-type="doi">10.1038/sj.onc.1206897</pub-id> </citation>
</ref>
<ref id="B67">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Strumpf</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Mao</surname>
<given-names>C.-A.</given-names>
</name>
<name>
<surname>Yamanaka</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Ralston</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Chawengsaksophak</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Beck</surname>
<given-names>F.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Cdx2 Is Required for Correct Cell Fate Specification and Differentiation of Trophectoderm in the Mouse Blastocyst</article-title>. <source>Development</source> <volume>132</volume>, <fpage>2093</fpage>&#x2013;<lpage>2102</lpage>. <pub-id pub-id-type="doi">10.1242/dev.01801</pub-id> </citation>
</ref>
<ref id="B68">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szabo&#x301;</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Biser</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Benko&#x30b;</surname>
<given-names>R.</given-names>
</name>
<name>
<surname>Suszta&#x301;k</surname>
<given-names>E.</given-names>
</name>
<name>
<surname>Susztak</surname>
<given-names>K.</given-names>
</name>
</person-group> (<year>2006</year>). <article-title>Poly(ADP-ribose) Polymerase Inhibitors Ameliorate Nephropathy of Type 2 Diabetic Leprdb/db Mice</article-title>. <source>Diabetes</source> <volume>55</volume>, <fpage>3004</fpage>&#x2013;<lpage>3012</lpage>. <pub-id pub-id-type="doi">10.2337/db06-0147</pub-id> </citation>
</ref>
<ref id="B69">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Szanto</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Hellebrand</surname>
<given-names>E. E.</given-names>
</name>
<name>
<surname>Bognar</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Tucsek</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Gallyas</surname>
<given-names>F.</given-names>
<suffix>Jr.</suffix>
</name>
<etal/>
</person-group> (<year>2009</year>). <article-title>PARP-1 Inhibition-Induced Activation of PI-3-Kinase-Akt Pathway Promotes Resistance to Taxol</article-title>. <source>Biochem. Pharmacol.</source> <volume>77</volume>, <fpage>1348</fpage>&#x2013;<lpage>1357</lpage>. <pub-id pub-id-type="doi">10.1016/j.bcp.2009.01.008</pub-id> </citation>
</ref>
<ref id="B70">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tan</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Zhang</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Miao</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Sui</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Tian</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2016</year>). <article-title>Dynamic Integrated Analysis of DNA Methylation and Gene Expression Profiles Inin Vivoandin Vitrofertilized Mouse post-implantation Extraembryonic and Placental Tissues</article-title>. <source>Mol. Hum. Reprod.</source> <volume>22</volume>, <fpage>485</fpage>&#x2013;<lpage>498</lpage>. <pub-id pub-id-type="doi">10.1093/molehr/gaw028</pub-id> </citation>
</ref>
<ref id="B71">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Tapodi</surname>
<given-names>A.</given-names>
</name>
<name>
<surname>Debreceni</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Hanto</surname>
<given-names>K.</given-names>
</name>
<name>
<surname>Bognar</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Wittmann</surname>
<given-names>I.</given-names>
</name>
<name>
<surname>Gallyas</surname>
<given-names>F.</given-names>
<suffix>Jr.</suffix>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Pivotal Role of Akt Activation in Mitochondrial protection and Cell Survival by poly(ADP-Ribose)polymerase-1 Inhibition in Oxidative Stress</article-title>. <source>J.&#x20;Biol. Chem.</source> <volume>280</volume>, <fpage>35767</fpage>&#x2013;<lpage>35775</lpage>. <pub-id pub-id-type="doi">10.1074/jbc.M507075200</pub-id> </citation>
</ref>
<ref id="B72">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Veres</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Radnai</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Gallyas</surname>
<given-names>F.</given-names>
<suffix>Jr.</suffix>
</name>
<name>
<surname>Varbiro</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Berente</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Osz</surname>
<given-names>E.</given-names>
</name>
<etal/>
</person-group> (<year>2004</year>). <article-title>Regulation of Kinase Cascades and Transcription Factors by a poly(ADP-Ribose) Polymerase-1 Inhibitor, 4-hydroxyquinazoline, in Lipopolysaccharide-Induced Inflammation in Mice</article-title>. <source>J.&#x20;Pharmacol. Exp. Ther.</source> <volume>310</volume>, <fpage>247</fpage>&#x2013;<lpage>255</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.104.065151</pub-id> </citation>
</ref>
<ref id="B73">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Virag</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Szabo</surname>
<given-names>C.</given-names>
</name>
</person-group> (<year>2002</year>). <article-title>The Therapeutic Potential of poly(ADP-Ribose) Polymerase Inhibitors</article-title>. <source>Pharmacol. Rev.</source> <volume>54</volume>, <fpage>375</fpage>&#x2013;<lpage>429</lpage>. <pub-id pub-id-type="doi">10.1124/pr.54.3.375</pub-id> </citation>
</ref>
<ref id="B74">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Waldenstr&#xf6;m</surname>
<given-names>U.</given-names>
</name>
<name>
<surname>Engstr&#xf6;m</surname>
<given-names>A.-B.</given-names>
</name>
<name>
<surname>Hellberg</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Nilsson</surname>
<given-names>S.</given-names>
</name>
</person-group> (<year>2009</year>). <article-title>Low-oxygen Compared with High-Oxygen Atmosphere in Blastocyst Culture, a Prospective Randomized Study</article-title>. <source>Fertil. Steril.</source> <volume>91</volume>, <fpage>2461</fpage>&#x2013;<lpage>2465</lpage>. <pub-id pub-id-type="doi">10.1016/j.fertnstert.2008.03.051</pub-id> </citation>
</ref>
<ref id="B75">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Will</surname>
<given-names>M. A.</given-names>
</name>
<name>
<surname>Clark</surname>
<given-names>N. A.</given-names>
</name>
<name>
<surname>Swain</surname>
<given-names>J.&#x20;E.</given-names>
</name>
</person-group> (<year>2011</year>). <article-title>Biological pH Buffers in IVF: Help or Hindrance to success</article-title>. <source>J.&#x20;Assist. Reprod. Genet.</source> <volume>28</volume>, <fpage>711</fpage>&#x2013;<lpage>724</lpage>. <pub-id pub-id-type="doi">10.1007/s10815-011-9582-0</pub-id> </citation>
</ref>
<ref id="B76">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xiao</surname>
<given-names>C.-Y.</given-names>
</name>
<name>
<surname>Chen</surname>
<given-names>M.</given-names>
</name>
<name>
<surname>Zsengell&#xe9;r</surname>
<given-names>Z.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>H.</given-names>
</name>
<name>
<surname>Kiss</surname>
<given-names>L.</given-names>
</name>
<name>
<surname>Kollai</surname>
<given-names>M.</given-names>
</name>
<etal/>
</person-group> (<year>2005</year>). <article-title>Poly(ADP-Ribose) Polymerase Promotes Cardiac Remodeling, Contractile Failure, and Translocation of Apoptosis-Inducing Factor in a Murine Experimental Model of Aortic Banding and Heart Failure</article-title>. <source>J.&#x20;Pharmacol. Exp. Ther.</source> <volume>312</volume>, <fpage>891</fpage>&#x2013;<lpage>898</lpage>. <pub-id pub-id-type="doi">10.1124/jpet.104.077164</pub-id> </citation>
</ref>
<ref id="B77">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Xu</surname>
<given-names>D.-P.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Meng</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>T.</given-names>
</name>
<name>
<surname>Zhou</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zheng</surname>
<given-names>J.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Natural Antioxidants in Foods and Medicinal Plants: Extraction, Assessment and Resources</article-title>. <source>Ijms</source> <volume>18</volume>, <fpage>96</fpage>. <pub-id pub-id-type="doi">10.3390/ijms18010096</pub-id> </citation>
</ref>
<ref id="B78">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yang</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>B.</given-names>
</name>
<name>
<surname>Xu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wang</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Wu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Shi</surname>
<given-names>C.</given-names>
</name>
<etal/>
</person-group> (<year>2017</year>). <article-title>Derivation of Pluripotent Stem Cells with <italic>In Vivo</italic> Embryonic and Extraembryonic Potency</article-title>. <source>Cell</source> <volume>169</volume>, <fpage>243</fpage>&#x2013;<lpage>257</lpage>. <pub-id pub-id-type="doi">10.1016/j.cell.2017.02.005</pub-id> </citation>
</ref>
<ref id="B79">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Yedwab</surname>
<given-names>G. A.</given-names>
</name>
<name>
<surname>Paz</surname>
<given-names>G.</given-names>
</name>
<name>
<surname>Homonnai</surname>
<given-names>T. Z.</given-names>
</name>
<name>
<surname>David</surname>
<given-names>M. P.</given-names>
</name>
<name>
<surname>Kraicer</surname>
<given-names>P. F.</given-names>
</name>
</person-group> (<year>1976</year>). <article-title>The Temperature, pH, and Partial Pressure of Oxygen in the Cervix and Uterus of Women and Uterus of Rats during the Cycle</article-title>. <source>Fertil. Steril.</source> <volume>27</volume>, <fpage>304</fpage>&#x2013;<lpage>309</lpage>. <pub-id pub-id-type="doi">10.1016/s0015-0282(16)41722-x</pub-id> </citation>
</ref>
<ref id="B80">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zakaria</surname>
<given-names>E. M.</given-names>
</name>
<name>
<surname>El-Bassossy</surname>
<given-names>H. M.</given-names>
</name>
<name>
<surname>El-Maraghy</surname>
<given-names>N. N.</given-names>
</name>
<name>
<surname>Ahmed</surname>
<given-names>A. F.</given-names>
</name>
<name>
<surname>Ali</surname>
<given-names>A. A.</given-names>
</name>
</person-group> (<year>2016</year>). <article-title>PARP-1 Inhibition Alleviates Diabetic Cardiac Complications in Experimental Animals</article-title>. <source>Eur. J.&#x20;Pharmacol.</source> <volume>791</volume>, <fpage>444</fpage>&#x2013;<lpage>454</lpage>. <pub-id pub-id-type="doi">10.1016/j.ejphar.2016.09.008</pub-id> </citation>
</ref>
<ref id="B81">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhang</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>C.</given-names>
</name>
<name>
<surname>Li</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Yao</surname>
<given-names>N.</given-names>
</name>
<name>
<surname>Yuan</surname>
<given-names>X.</given-names>
</name>
<name>
<surname>Yu</surname>
<given-names>A.</given-names>
</name>
<etal/>
</person-group> (<year>2010</year>). <article-title>Intracellular Redox Imbalance and Extracellular Amino Acid Metabolic Abnormality Contribute to Arsenic-Induced Developmental Retardation in Mouse Preimplantation Embryos</article-title>. <source>J.&#x20;Cel. Physiol.</source> <volume>222</volume>, <fpage>444</fpage>&#x2013;<lpage>455</lpage>. <pub-id pub-id-type="doi">10.1002/jcp.21966</pub-id> </citation>
</ref>
<ref id="B82">
<citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname>Zhao</surname>
<given-names>Z. H.</given-names>
</name>
<name>
<surname>Zh</surname>
<given-names>D.</given-names>
</name>
<name>
<surname>Liu</surname>
<given-names>Y.</given-names>
</name>
<name>
<surname>Zh</surname>
<given-names>Q.</given-names>
</name>
<name>
<surname>Qiu</surname>
<given-names>J.</given-names>
</name>
<name>
<surname>Ch</surname>
<given-names>X.</given-names>
</name>
<etal/>
</person-group> (<year>2021</year>). <article-title>Embryotoxic Effects of Tribromophenol on Early post-implantation Development of Mouse Embryos <italic>In Vitro</italic>
</article-title>. <source>Environ. Sci. Pollut. Res.</source> <comment>in press</comment> <pub-id pub-id-type="doi">10.1007/s11356-021-16614-3</pub-id> </citation>
</ref>
</ref-list>
</back>
</article>